101
|
Pardo J, Murcia M, Soto R, Gonzalez J, Montemuiño S, Alastuey I, Jimenez E, Ortiz I. An Emulsion Containing Hyaluronic Acid and Chondroitin Sulfate for Prevention and Treatment of Radiation Dermatitis in Breast Cancer Patients - A Randomized Study. Int J Radiat Oncol Biol Phys 2015. [DOI: 10.1016/j.ijrobp.2015.07.574] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
102
|
|
103
|
Stephan J, Cohen E, Gonzalez J. BRCAness in endometrial cancer. Gynecol Oncol 2015. [DOI: 10.1016/j.ygyno.2015.07.044] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
104
|
Perez-Flecha F, Sánchez-Jáuregui E, Villegas D, García-Serrano G, Sagüillo K, Page I, Gonzalez J, Eslava J, Acero J. Our experience with modified Risdon approach for subcondylar mandibular fractures and review of literature. Int J Oral Maxillofac Surg 2015. [DOI: 10.1016/j.ijom.2015.08.737] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
105
|
Nakhutina L, Margolis S, Gonzalez J, Chen G, Medina A, Grant A. C-41Prospective Memory Performance is Associated with Antiepileptic Drug Adherence in Ethnically Diverse Patients with Epilepsy. Arch Clin Neuropsychol 2015. [DOI: 10.1093/arclin/acv047.243] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
106
|
Iglesias M, Butrón P, Osuna-Leal A, Abarca-Perez L, Sosa-Ascencio M, Moran-Romero M, Cruz-Reyes A, Pineda-Gutierrez F, Leon-Lopez D, García-Alvarez M, Alberu J, Vilatoba M, Leal-Villalpando R, Zamudio-Bautista J, Acosta-Nava V, Gonzalez J. Is Mexico Ready for Face Transplantation? Transplant Proc 2015; 47:1998-2002. [DOI: 10.1016/j.transproceed.2015.05.020] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2015] [Revised: 05/04/2015] [Accepted: 05/15/2015] [Indexed: 02/05/2023]
|
107
|
Torrente D, Cabezas R, Avila M, Sanchez Y, Morales L, Ashraf GM, Barreto GE, Gonzalez J, Aliev G. Mechanisms of PDGFRalpha promiscuity and PDGFRbeta specificity in association with PDGFB. Front Biosci (Elite Ed) 2015; 7:434-46. [PMID: 25961423 DOI: 10.2741/e741] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Platelet-derived growth factor receptor alpha (PDGFRalpha) interacts with PDGFs A, B, C and AB, while PDGFRbeta binds to PDGFs B and D, thus suggesting that PDGFRalpha is more promiscuous than PDGFRbeta. The structural analysis of PDGFRalpha-PDGFA and PDGFRalpha-PDGFB complexes and a molecular explanation for the promiscuity of PDGFRalpha and the specificity of PDGFRbeta remain unclear. In the present study, we modeled the three extracellular domains of PDGFRalpha using a previous crystallographic structure of PDGFRbeta as a template. Additionally, we analyzed the interacting residues of PDGFRalpha-PDGFA and PDGFRalpha-PDGFB complexes using docking simulations. The validation of the resulting complexes was evaluated by molecular dynamics simulations. Structural analysis revealed that changes of non-aromatic amino acids in PDGFRalpha to aromatic amino acids in PDGFRbeta (I139F, P267F and N204Y) may be involved in the promiscuity of PDGFRalpha. Indeed, substitution of amino acids with few probabilities of rotamer changes in PDGFRbeta (M133A, N163E and N179S) and energy stability due to the formation of hydrogen bond in PDGFRbeta could explain the specificity of PDGFRbeta. These results may be used as an input for a better and more specific drug and peptide design targeting diseases related with the malfunction of PDGFs and PDGFRalpha such as cancer and atherosclerosis.
Collapse
Affiliation(s)
| | | | | | | | | | - Ghulam Md Ashraf
- King Fahd Medical Research Center, King Abdulaziz University, P.O. Box 80216, Jeddah 21589, Saudi Arabia
| | | | - Janneth Gonzalez
- Departamento de Nutricion y Bioquimica, Facultad de Ciencias, Pontificia Universidad Javeriana, Bogota D.C., Colombia. Carrera 7ª # 43-82, Carlos Ortiz Bldg, S. J.; Lab. 107/108,
| | - Gjumrackh Aliev
- GALLY International Biomedical Research Consulting LLC., 7733 Louis Pasteur Drive, #330, San Antonio, TX, USA 78229, AND School of Health Science and Healthcare Administration, University of Atlanta, E. Johns Crossing, #175, Johns Creek, GA, USA 30097
| |
Collapse
|
108
|
Dominguez-Rodriguez A, Abreu-Gonzalez P, Jimenez-Sosa A, Gonzalez J, Caballero-Estevez N, Martin-Casanas FV, Lara-Padron A, Aranda JM. The impact of frailty in older patients with non-ischaemic cardiomyopathy after implantation of cardiac resynchronization therapy defibrillator. Europace 2015; 17:598-602. [DOI: 10.1093/europace/euu333] [Citation(s) in RCA: 35] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/30/2023] Open
|
109
|
Green B, Gonzalez J, Thomas K, Bryans J, Stevenson E, Rumbold P. Reproducibility of appetite- and metabolism-related peptides following fingertip-capillary blood sampling. Appetite 2015. [DOI: 10.1016/j.appet.2014.12.128] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
110
|
Luna M, Burt D, Rivera-Andrade A, Chen D, Gonzalez J, Mendoza C. A cardiovascular disease surveillance study in Santiago atitlán,
Guatemala: A model of community-centered, participatory health
research. Ann Glob Health 2015. [DOI: 10.1016/j.aogh.2015.02.725] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
111
|
Gonzalez J, Carral-Fernandez L, Rio-Hortega I, Gil-Camarero E, Gonzalez-Gomez A, Benito-Gonzalez P, Garcia-Quevedo E, Gonzalez-Ortiz C, Sancristobal R, Velar-Castellanos I, Boteon G, del Barrio AG. Association Between Low Serum Cholesterol and Impulsivity Behaviours in Eating Disorders Patients Compared with a Control Group. Eur Psychiatry 2015. [DOI: 10.1016/s0924-9338(15)30158-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
112
|
Fernández E, Martin J, Vildósola P, Estay J, de Oliveira Júnior OB, Gordan V, Mjor I, Gonzalez J, Loguercio AD, Moncada G. Sealing Composite With Defective Margins, Good Care or Over Treatment? Results of a 10-year Clinical Trial. Oper Dent 2015; 40:144-52. [PMID: 25535778 DOI: 10.2341/14-143-c] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
SUMMARY
Purpose
The objective of this study was to clinically evaluate sealed composite restorations after 10 years and compare their behavior with respect to controls.
Methods and Materials
The cohort consisted of 20 patients aged 18 to 80 years with 80 composite restorations. All participants in the sealing and no-treatment groups presented with clinical features for the marginal adaptation that deviated from the ideal and were rated Bravo (United States Public Health Service criteria). Composites with Alfa values for the marginal adaptation were used as the positive control.
Results
The marginal adaptation behavior was similar between the sealing and control (+) groups, with a high frequency of Bravo values in the 10th year (80% and 51%, respectively). Most of the no-treatment (-) group maintained the Bravo values (91%) for 10 years, although some restorations (9%) progressed to Charlie values. The anatomy parameter differed significantly between the first and 10th years, with deterioration in all three groups (p<0.05). The secondary caries parameter had a similar behavior in the three groups (p>0.05).
Conclusions
Sealing the margins of the composite resin restorations had no significant effect compared with the control groups, under the conditions of this study. Sealing the restorations substantially improved the marginal staining and marginal adaptation parameters, although by the tenth year they were similar to the group without intervention.
Collapse
Affiliation(s)
- E Fernández
- Eduardo Fernández, PhD (c), associate professor, Restorative Dentistry, University of Chile, Santiago, Chile
| | - J Martin
- Javier Martin, DDS, professor, Restorative Dentistry, University of Chile, Santiago, Chile
| | - P Vildósola
- Patricio Vildósola, DDS, professor, Restorative Dentistry, University of Chile, Santiago, Chile
| | - J Estay
- Juan Estay, DDS, professor, Restorative Dentistry, University of Chile, Santiago, Chile
| | | | - V Gordan
- Valeria V Gordan, DDS, MS, MS-CI professor, Restorative Dental Sciences Department, Division of Operative Dentistry, University of Florida, College of Dentistry
| | - I Mjor
- Ivar A Mjor, professor emeritus, Restorative Dental Sciences Department, Division of Operative Dentistry, University of Florida, College of Dentistry
| | - J Gonzalez
- Jeannette Gonzalez, University of Chile, Santiago, Chile
| | - AD Loguercio
- Alessandro D Loguercio, DDS, Ms, PhD, professor, Restorative Dentistry, Ponta Grossa State University, Ponta Grossa, PR, Brazil
| | - G Moncada
- Gustavo Moncada, PhD (c) professor, Restorative Dentistry, Universidad Mayor, Santiago, Chile
| |
Collapse
|
113
|
Gonzalez J. Síndrome del canal radial: nueva técnica de liberación endoscópica. Rev Iberoam Cir Mano 2014. [DOI: 10.1055/s-0037-1607113] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
Abstract
El objetivo de este trabajo es presentar una nueva técnica endoscópica para la liberación de la rama motora del nervio radial en el síndrome del canal radial.El síndrome del canal radial es la neuropatía compresiva de la rama motora del nervio radial que, muy a menudo, requiere la liberación quirúrgica mediante la apertura completa de las estructuras que producen la compresión.Las vías de abordaje convencionales son amplias, requieren disecciones agresivas y laboriosas. El pequeño tamaño del nervio y su posición profunda entre vientres musculares hace que, fácilmente, pueda ser dañado durante su disección si la visualización no es correcta en todo momento.Presentamos una nueva técnica que combina el marcaje preoperatorio de la posición del nervio mediante ecografía y liberación mediante técnica endoscópica.Esta técnica permite un abordaje quirúrgico mucho menor, una mejor visualización del nervio en todo su recorrido y de las estructuras anatómicas durante la disección.Se presenta una serie de 22 intervenciones en 20 pacientes intervenidos entre 2010 y 2014. En 14 casos los resultados fueron excelentes, 5 buenos y 3 regulares. Las complicaciones fueron en un caso una lesión parcial del nervio durante la cirugía y 4 casos de paresia a la extensión de los dedos que se recuperaron completamente en todos los casos entre las 3 y 6 semanas.
Collapse
|
114
|
Ávila Rodriguez M, Garcia-Segura LM, Cabezas R, Torrente D, Capani F, Gonzalez J, Barreto GE. Tibolone protects T98G cells from glucose deprivation. J Steroid Biochem Mol Biol 2014; 144 Pt B:294-303. [PMID: 25086299 DOI: 10.1016/j.jsbmb.2014.07.009] [Citation(s) in RCA: 47] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/14/2014] [Revised: 07/23/2014] [Accepted: 07/24/2014] [Indexed: 12/22/2022]
Abstract
The steroidal drug Tibolone is used for the treatment of climacteric symptoms and osteoporosis in post-menopausal women. Although Tibolone has been shown to exert neuroprotective actions after middle cerebral artery occlusion, its specific actions on glial cells have received very little attention. In the present study we have assessed whether Tibolone exerts protective actions in a human astrocyte cell model, the T98G cells, subjected to glucose deprivation. Our findings indicate that Tibolone decreases the effects of glucose deprivation on cell death, nuclear fragmentation, superoxide ion production, mitochondrial membrane potential, cytoplasmic calcium concentration and morphological parameters. These findings suggest that glial cells may participate in the neuroprotective actions of Tibolone in the brain.
Collapse
Affiliation(s)
- Marco Ávila Rodriguez
- Departamento de Nutrición y Bioquímica, Facultad de Ciencias, Pontificia Universidad Javeriana, Bogotá D.C., Colombia
| | | | - Ricardo Cabezas
- Departamento de Nutrición y Bioquímica, Facultad de Ciencias, Pontificia Universidad Javeriana, Bogotá D.C., Colombia
| | - Daniel Torrente
- Department of Physics and Astronomy, The University of Texas at San Antonio, United States
| | - Francisco Capani
- Laboratorio de Citoarquitectura y Plasticidad Neuronal, Instituto de Investigaciones cardiológicas Prof. Dr. Alberto C. Taquini (ININCA), Facultad de Medicina, UBA-CONICET, Marcelo T. de Alvear 2270, C1122AAJ Buenos Aires, Argentina
| | - Janneth Gonzalez
- Departamento de Nutrición y Bioquímica, Facultad de Ciencias, Pontificia Universidad Javeriana, Bogotá D.C., Colombia
| | - George E Barreto
- Departamento de Nutrición y Bioquímica, Facultad de Ciencias, Pontificia Universidad Javeriana, Bogotá D.C., Colombia.
| |
Collapse
|
115
|
Stupakiewicz A, Chizhik A, Tekielak M, Zhukov A, Gonzalez J, Maziewski A. Direct imaging of the magnetization reversal in microwires using all-MOKE microscopy. Rev Sci Instrum 2014; 85:103702. [PMID: 25362398 DOI: 10.1063/1.4896758] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
We report a method of imaging of the magnetization reversal process using analysis of real-time images of magnetic domain structures in cylindrically shaped microwires. This method uses wide-field polarizing optical microscopy and is based on the magneto-optical Kerr effect (MOKE). The aperture diaphragm in MOKE microscope was used to control the incident angles of the light rays that reached the non-planar surface of the microwire and also determined the MOKE geometries. The movement of the non-central position of the hole in this diaphragm leads to a change in the orientation of the plane of incidence of the light along the perpendicular or the parallel direction to the axial direction of the wire. The visualization of the surface magnetic domain structures is obtained using polar and longitudinal MOKE geometries. The hysteresis loops were obtained by plotting the averaged image contrast as a function of the external magnetic field. The separation of the all-magnetization components is performed using different MOKE geometries in a microscope. We demonstrate the use of vector magnetometry to analyze the orientation of the magnetization in a cylindrically shaped microwire under the influence of an external magnetic field.
Collapse
Affiliation(s)
- A Stupakiewicz
- Laboratory of Magnetism, Faculty of Physics, University of Bialystok, 15-424 Bialystok, Poland
| | - A Chizhik
- Universidad del País Vasco, UPV/EHU, San Sebastián, Spain
| | - M Tekielak
- Laboratory of Magnetism, Faculty of Physics, University of Bialystok, 15-424 Bialystok, Poland
| | - A Zhukov
- Universidad del País Vasco, UPV/EHU, San Sebastián, Spain
| | - J Gonzalez
- Universidad del País Vasco, UPV/EHU, San Sebastián, Spain
| | - A Maziewski
- Laboratory of Magnetism, Faculty of Physics, University of Bialystok, 15-424 Bialystok, Poland
| |
Collapse
|
116
|
Taylor MM, Newman DR, Gonzalez J, Skinner J, Khurana R, Mickey T. HIV status and viral loads among men testing positive for rectal gonorrhoea and chlamydia, Maricopa County, Arizona, USA, 2011-2013. HIV Med 2014; 16:249-54. [PMID: 25230929 DOI: 10.1111/hiv.12192] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 07/16/2014] [Indexed: 11/29/2022]
Abstract
OBJECTIVES Men diagnosed with rectal gonorrhoea (GC) and chlamydia (CT) have engaged in unprotected receptive anal intercourse. We reviewed the HIV positivity and HIV viral loads (VLs) of men who had rectal GC and CT testing to evaluate potential HIV acquisition and transmission risk. METHODS Rectal GC and CT testing data for men attending the Maricopa County STD clinic during the period from 1 October 2011 to 30 September 2013 were cross-matched with HIV surveillance data to identify men with HIV coinfection. We examined HIV status, HIV diagnosis date, and the values of VL collected nearest to the date of reported rectal infection. RESULTS During the 2-year time period, 1591 men were tested for rectal GC and CT. Of the men tested, 506 (31.8%) were positive for GC (13.2%), CT (12.2%) or both (6.4%); 119 (23.5%) of those with rectal GC or CT were coinfected with HIV. Among the 275 men with HIV at the time of rectal testing, 54 (19.6%) had no reported VL; 63 (22.9%) had an undetectable VL (< 20 HIV-1 RNA copies/mL) and 158 (57.4%) had a detectable VL collected within 1 year of rectal diagnosis. Mean VL was higher among HIV and rectal GC/CT coinfected cases compared with men with HIV alone (174 316 vs. 57 717 copies/mL, respectively; P = 0.04). CONCLUSIONS Approximately one-third of men undergoing rectal testing were positive for GC or CT and one-quarter of men with rectal GC or CT also had HIV infection. Of the HIV-infected men tested for rectal GC or CT, more than half had a detectable VL collected near the time of rectal testing, demonstrating a risk for transmitting HIV.
Collapse
Affiliation(s)
- M M Taylor
- Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA; Maricopa County Department of Public Health, Phoenix, AZ, USA; STD Program, Arizona Department of Health Services, Phoenix, AZ, USA
| | | | | | | | | | | |
Collapse
|
117
|
Zaruma CL, Arregui E, Cano JM, Gonzalez J, Amo-Salas M, Lopez C, Moreno JMB. P17.52 * ANALYSIS OF RISK AND PROGNOSIS FACTORS IN GLIOBLASTOMA - OUR EXPERIENCE IN 104 PATIENTS. Neuro Oncol 2014. [DOI: 10.1093/neuonc/nou174.381] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
118
|
Pineda E, Valduvieco I, Pujol T, Oleaga L, Ribalta T, Caral L, Gonzalez J, Boget T, Graus F, Verger E. P17.70 * CAN ELDERLY PATIENTS WITH GLIOBLASTOMA BENEFIT FROM CONVENTIONAL CHEMO-RADIOTHERAPY TREATMENT? Neuro Oncol 2014. [DOI: 10.1093/neuonc/nou174.399] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
119
|
Cabezas R, Avila M, Gonzalez J, El-Bachá RS, Báez E, García-Segura LM, Jurado Coronel JC, Capani F, Cardona-Gomez GP, Barreto GE. Astrocytic modulation of blood brain barrier: perspectives on Parkinson's disease. Front Cell Neurosci 2014; 8:211. [PMID: 25136294 PMCID: PMC4120694 DOI: 10.3389/fncel.2014.00211] [Citation(s) in RCA: 266] [Impact Index Per Article: 26.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/29/2014] [Accepted: 07/14/2014] [Indexed: 12/21/2022] Open
Abstract
The blood–brain barrier (BBB) is a tightly regulated interface in the Central Nervous System (CNS) that regulates the exchange of molecules in and out from the brain thus maintaining the CNS homeostasis. It is mainly composed of endothelial cells (ECs), pericytes and astrocytes that create a neurovascular unit (NVU) with the adjacent neurons. Astrocytes are essential for the formation and maintenance of the BBB by providing secreted factors that lead to the adequate association between the cells of the BBB and the formation of strong tight junctions. Under neurological disorders, such as chronic cerebral ischemia, brain trauma, Epilepsy, Alzheimer and Parkinson’s Diseases, a disruption of the BBB takes place, involving a lost in the permeability of the barrier and phenotypical changes in both the ECs and astrocytes. In this aspect, it has been established that the process of reactive gliosis is a common feature of astrocytes during BBB disruption, which has a detrimental effect on the barrier function and a subsequent damage in neuronal survival. In this review we discuss the implications of astrocyte functions in the protection of the BBB, and in the development of Parkinson’s disease (PD) and related disorders. Additionally, we highlight the current and future strategies in astrocyte protection aimed at the development of restorative therapies for the BBB in pathological conditions.
Collapse
Affiliation(s)
- Ricardo Cabezas
- Departamento de Nutrición y Bioquímica, Facultad de Ciencias, Pontificia Universidad Javeriana Bogotá, D.C., Colombia
| | - Marcos Avila
- Departamento de Nutrición y Bioquímica, Facultad de Ciencias, Pontificia Universidad Javeriana Bogotá, D.C., Colombia
| | - Janneth Gonzalez
- Departamento de Nutrición y Bioquímica, Facultad de Ciencias, Pontificia Universidad Javeriana Bogotá, D.C., Colombia
| | | | - Eliana Báez
- Departamento de Nutrición y Bioquímica, Facultad de Ciencias, Pontificia Universidad Javeriana Bogotá, D.C., Colombia
| | | | - Juan Camilo Jurado Coronel
- Departamento de Nutrición y Bioquímica, Facultad de Ciencias, Pontificia Universidad Javeriana Bogotá, D.C., Colombia
| | - Francisco Capani
- Laboratorio de Citoarquitectura y Plasticidad Neuronal, Facultad de Medicina, Instituto de Investigaciones cardiológicas Prof. Dr. Alberto C. Taquini (ININCA), UBA-CONICET, Buenos Aires Argentina
| | - Gloria Patricia Cardona-Gomez
- Cellular and Molecular Neurobiology Area, Group of Neuroscience of Antioquia, Faculty of Medicine, SIU, University of Antioquia UdeA Medellín, Colombia
| | - George E Barreto
- Departamento de Nutrición y Bioquímica, Facultad de Ciencias, Pontificia Universidad Javeriana Bogotá, D.C., Colombia
| |
Collapse
|
120
|
Abstract
N-methyl-D-aspartate ionotropic glutamate receptor (NMDARs) is a ligand-gated ion channel that plays a critical role in excitatory neurotransmission, brain development, synaptic plasticity associated with memory formation, central sensitization during persistent pain, excitotoxicity and neurodegenerative diseases in the central nervous system (CNS). Within iGluRs, NMDA receptors have been the most actively investigated for their role in neurological diseases, especially neurodegenerative pathologies such as Alzheimer's and Parkinson's diseases. It has been demonstrated that excessive activation of NMDA receptors (NMDARs) plays a key role in mediating some aspects of synaptic dysfunction in several CNS disorders, so extensive research has been directed on the discovery of compounds that are able to reduce NMDARs activity. This review discusses the role of NMDARs on neurological pathologies and the possible therapeutic use of agents that target this receptor. Additionally, we delve into the role of NMDARs in Alzheimer's and Parkinson's diseases and the receptor antagonists that have been tested on in vivo models of these pathologies. Finally, we put into consideration the importance of antioxidants to counteract oxidative capacity of the signaling cascade in which NMDARs are involved.
Collapse
Affiliation(s)
- Janneth Gonzalez
- 1Departamento de Nutrición y Bioquímica, Facultad de Ciencias, Pontificia Universidad Javeriana, Bogotá D.C., Colombia
| | | | | | | | | | | |
Collapse
|
121
|
Rubio N, Hastedt M, Gonzalez J, Pragst F. O11: Differentiation between chewing of coca leaves and abuse of cocaine by hair analysis. Toxicologie Analytique et Clinique 2014. [DOI: 10.1016/s2352-0078(14)70019-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
122
|
Ávila MF, Torrente D, Cabezas R, Morales L, García-Segura LM, Gonzalez J, Barreto GE. Structural insights from GRP78–NF-κB binding interactions: A computational approach to understand a possible neuroprotective pathway in brain injuries. J Theor Biol 2014; 345:43-51. [DOI: 10.1016/j.jtbi.2013.12.010] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/19/2013] [Revised: 09/23/2013] [Accepted: 12/09/2013] [Indexed: 10/25/2022]
|
123
|
Fernandez B, Gonzalez J, Escribano N, Gomes G, Da Silva D, Fuentes MV, Miguez M, Ceballos L. Orthodontic extrusion, an alternative to restitute the biologic width to the anterior sector. J Clin Exp Dent 2014. [DOI: 10.4317/jced.17643808] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
|
124
|
Garcia Martin A, Fernandez Golfin C, Salido Tahoces L, Fernandez Santos S, Jimenez Nacher J, Moya Mur J, Velasco Valdazo E, Hernandez Antolin R, Zamorano Gomez J, Veronesi F, Corsi C, Caiani E, Lamberti C, Tsang W, Holmgren C, Guo X, Bateman M, Iaizzo P, Vannier M, Lang R, Patel A, Adamayn K, Tumasyan LR, Chilingaryan A, Nasr G, Eleraki A, Farouk N, Axelsson A, Langhoff L, Jensen M, Vejlstrup N, Iversen K, Bundgaard H, Watanabe T, Iwai-Takano M, Attenhofer Jost CH, Pfyffer M, Seifert B, Scharf C, Candinas R, Medeiros-Domingo A, Chin JY, Yoon H, Vollbon W, Singbal Y, Rhodes K, Wahi S, Katova TM, Simova II, Hristova K, Kostova V, Pauncheva B, Bircan A, Sade L, Eroglu S, Pirat B, Okyay K, Bal U, Muderrisoglu H, Heggemann F, Buggisch H, Welzel G, Doesch C, Hansmann J, Schoenberg S, Borggrefe M, Wenz F, Papavassiliu T, Lohr F, Roussin I, Drakopoulou M, Rosen S, Sharma R, Prasad S, Lyon A, Carpenter J, Senior R, Breithardt OA, Razavi H, Arya A, Nabutovsky Y, Ryu K, Gaspar T, Kosiuk J, Eitel C, Hindricks G, Piorkowski C, Pires S, Nunes A, Cortez-Dias N, Belo A, Zimbarra Cabrita I, Sousa C, Pinto F, Baron T, Johansson K, Flachskampf F, Christersson C, Pires S, Cortez-Dias N, Nunes A, Belo A, Zimbarra Cabrita I, Sousa C, Pinto F, Santoro A, Federico Alvino F, Giovanni Antonelli G, Raffaella De Vito R, Roberta Molle R, Sergio Mondillo S, Gustafsson M, Alehagen U, Johansson P, Tsukishiro Y, Onishi T, Chimura M, Yamada S, Taniguchi Y, Yasaka Y, Kawai H, Souza JRM, Zacharias LGT, Pithon KR, Ozahata TM, Cliquet AJ, Blotta MH, Nadruz WJ, Fabiani I, Conte L, Cuono C, Liga R, Giannini C, Barletta V, Nardi C, Delle Donne M, Palagi C, Di Bello V, Glaveckaite S, Valeviciene N, Palionis D, Laucevicius A, Hristova K, Bogdanova V, Ferferieva V, Shiue I, Castellon X, Boles U, Rakhit R, Shiu MF, Gilbert T, Papachristidis A, Henein MY, Westholm C, Johnson J, Jernberg T, Winter R, Ghosh Dastidar A, Augustine D, Cengarle M, Mcalindon E, Bucciarelli-Ducci C, Nightingale A, Onishi T, Watanabe T, Fujita M, Mizukami Y, Sakata Y, Nakatani S, Nanto S, Uematsu M, Saraste A, Luotolahti M, Varis A, Vasankari T, Tunturi S, Taittonen M, Rautakorpi P, Airaksinen J, Ukkonen H, Knuuti J, Boshchenko A, Vrublevsky A, Karpov R, Yoshikawa H, Suzuki M, Hashimoto G, Kusunose Y, Otsuka T, Nakamura M, Sugi K, Rosner S, Orban M, Lesevic H, Karl M, Hadamitzky M, Sonne C, Panaro A, Martinez F, Huguet M, Moral S, Palet J, Oller G, Cuso I, Jornet A, Rodriguez Palomares J, Evangelista A, Stoebe S, Tarr A, Pfeiffer D, Hagendorff A, Gilmanov D, Baroni M, Cerone E, Galli E, Berti S, Glauber M, Soesanto A, Yuniadi Y, Mansyur M, Kusmana D, Venkateshvaran A, Dash PK, Sola S, Govind SC, Shahgaldi K, Winter R, Brodin LA, Manouras A, Dokainish H, Sadreddini M, Nieuwlaat R, Lonn E, Healey J, Nguyen V, Cimadevilla C, Dreyfus J, Codogno I, Vahanian A, Messika-Zeitoun D, Lim YJ, Kawamura A, Kawano S, Polte C, Gao S, Lagerstrand K, Cederbom U, Bech-Hanssen O, Baum J, Beeres F, Van Hall S, Boering Y, Zeus T, Kehmeier E, Kelm M, Balzer J, Della Mattia A, Pinamonti B, Abate E, Nicolosi G, Proclemer A, Bassetti M, Luzzati R, Sinagra G, Hlubocka Z, Jiratova K, Dostalova G, Hlubocky J, Dohnalova A, Linhart A, Palecek T, Sonne C, Lesevic H, Karl M, Rosner S, Hadamitzky M, Ott I, Malev E, Reeva S, Zemtsovsky E, Igual Munoz B, Alonso Fernandez Pau P, Miro Palau Vicente V, Maceira Gonzalez Alicia A, Estornell Erill J, Andres La Huerta A, Donate Bertolin L, Valera Martinez F, Salvador Sanz Antonio A, Montero Argudo Anastasio A, Nemes A, Kalapos A, Domsik P, Chadaide S, Sepp R, Forster T, Onaindia J, Arana X, Cacicedo A, Velasco S, Rodriguez I, Capelastegui A, Sadaba M, Gonzalez J, Salcedo A, Laraudogoitia E, Archontakis S, Gatzoulis K, Vlasseros I, Arsenos P, Tsiachris D, Vouliotis A, Sideris S, Karistinos G, Kalikazaros I, Stefanadis C, Ancona R, Comenale Pinto S, Caso P, Coppola M, Arenga F, Cavallaro C, Vecchione F, D'onofrio A, Calabro R, Correia CE, Moreira D, Cabral C, Santos J, Cardoso J, Igual Munoz B, Maceira Gonzalez A, Estornell Erill Jordi J, Jimenez Carreno R, Arnau Vives M, Monmeneu Menadas J, Domingo-Valero D, Sanchez Fernandez E, Montero Argudo Anastasio A, Zorio Grima E, Cincin A, Tigen K, Karaahmet T, Dundar C, Sunbul M, Guler A, Bulut M, Basaran Y, Mordi I, Carrick D, Berry C, Tzemos N, Cruz I, Ferreira A, Rocha Lopes L, Joao I, Almeida A, Fazendas P, Cotrim C, Pereira H, Ochoa JP, Fernandez A, Filipuzzi J, Casabe J, Salmo J, Vaisbuj F, Ganum G, Di Nunzio H, Veron L, Guevara E, Salemi V, Nerbass F, Portilho N, Ferreira Filho J, Pedrosa R, Arteaga-Fernandez E, Mady C, Drager L, Lorenzi-Filho G, Marques J, Almeida AMG, Menezes M, Silva G, Placido R, Amaro C, Brito D, Diogo A, Lourenco MR, Azevedo O, Moutinho J, Nogueira I, Machado I, Portugues J, Quelhas I, Lourenco A, Calore C, Muraru D, Melacini P, Badano L, Mihaila S, Puma L, Peluso D, Casablanca S, Ortile A, Iliceto S, Kang MK, Yu S, Park J, Kim S, Park T, Mun HS, C S, Cho SR, Han S, Lee N, Khalifa EA, Hamodraka E, Kallistratos M, Zacharopoulou I, Kouremenos N, Mavropoulos D, Tsoukas A, Kontogiannis N, Papanikolaou N, Tsoukanas K, Manolis A, Villagraz Tecedor L, Jimenez Lopez Guarch C, Alonso Chaterina S, Blazquez Arrollo L, Lopez Melgar B, Veitia Sarmiento A, Mayordomo Gomez S, Escribano Subias M, Lichodziejewska B, Kurnicka K, Goliszek S, Dzikowska Diduch O, Kostrubiec M, Krupa M, Grudzka K, Ciurzynski M, Palczewski P, Pruszczyk P, Sakata K, Ishiguro M, Kimura G, Uesugo Y, Takemoto K, Minamishima T, Futuya M, Matsue S, Satoh T, Yoshino H, Signorello M, Gianturco L, Colombo C, Stella D, Atzeni F, Boccassini L, Sarzi-Puttini P, Turiel M, Kinova E, Deliiska B, Krivoshiev S, Goudev A, De Stefano F, Santoro C, Buonauro A, Schiano-Lomoriello V, Muscariello R, De Palma D, Galderisi M, Ranganadha Babu B, Chidambaram S, Sangareddi V, Dhandapani V, Ravi M, Meenakshi K, Muthukumar D, Swaminathan N, Ravishankar G, Bruno RM, Giardini G, Catizzo B, Brustia R, Malacrida S, Armenia S, Cauchy E, Pratali L, Cesana F, Alloni M, Vallerio P, De Chiara B, Musca F, Belli O, Ricotta R, Siena S, Moreo A, Giannattasio C, Magnino C, Omede' P, Avenatti E, Presutti D, Sabia L, Moretti C, Bucca C, Gaita F, Veglio F, Milan A, Eichhorn J, Springer W, Helling A, Alarajab A, Loukanov T, Ikeda M, Kijima Y, Akagi T, Toh N, Oe H, Nakagawa K, Tanabe Y, Watanabe N, Ito H, Hascoet S, Hadeed K, Marchal P, Bennadji A, Peyre M, Dulac Y, Heitz F, Alacoque X, Chausseray G, Acar P, Kong W, Ling L, Yip J, Poh K, Vassiliou V, Rekhraj S, Hoole S, Watkinson O, Kydd A, Boyd J, Mcnab D, Densem C, Shapiro L, Rana B, Potpara T, Djikic D, Polovina M, Marcetic Z, Peric V, Lip G, Gaudron P, Niemann M, Herrmann S, Hu K, Strotmann J, Beer M, Bijnens B, Liu D, Ertl G, Weidemann F, Peric V, Jovanovic A, Djikic D, Otasevic P, Kochanowski J, Piatkowski R, Scislo P, Grabowski M, Marchel M, Opolski G, Bandera F, Guazzi M, Arena R, Corra U, Ghio S, Forfia P, Rossi A, Dini F, Cahalin L, Temporelli L, Rallidis L, Tsangaris I, Makavos G, Anthi A, Pappas A, Orfanos S, Lekakis J, Anastasiou-Nana M, Kuznetsov VA, Krinochkin DV, Yaroslavskaya EI, Zaharova EH, Pushkarev GS, Mizia-Stec K, Wita K, Mizia M, Loboz-Grudzien K, Szwed H, Kowalik I, Kukulski T, Gosciniak P, Kasprzak J, Plonska-Gosciniak E, Cimino S, Pedrizzetti G, Tonti G, Cicogna F, Petronilli V, De Luca L, Iacoboni C, Agati L, Hoffmann R, Barletta G, Von Bardeleben S, Kasprzak J, Greis C, Vanoverschelde J, Becher H, Galrinho A, Moura Branco L, Fiarresga A, Cacela D, Ramos R, Cruz Ferreira R, Van Den Oord S, Akkus Z, Bosch J, Renaud G, Sijbrands E, Verhagen H, Van Der Lugt A, Van Der Steen A, Schinkel A, Mordi I, Tzemos N, Stanton T, Delgado D, Yu E, Drakopoulou M, Gonzalez-Gonzalez A, Karonis T, Roussin I, Babu-Narayan S, Swan L, Senior R, Li W, Parisi V, Pagano G, Pellegrino T, Femminella G, De Lucia C, Formisano R, Cuocolo A, Perrone Filardi P, Leosco D, Rengo G, Unlu S, Farsalinos K, Amelot K, Daraban A, Ciarka A, Delcroix M, Voigt J, Miskovic A, Poerner T, Goebel B, Stiller C, Moritz A, Sakata K, Uesugo Y, Kimura G, Ishiguro M, Takemoto K, Minamishima T, Futuya M, Satoh T, Yoshino H, Miyoshi T, Tanaka H, Kaneko A, Matsumoto K, Imanishi J, Motoji Y, Mochizuki Y, Minami H, Kawai H, Hirata K, Wutthimanop A, See O, Vathesathokit P, Yamwong S, Sritara P, Rosner A, Kildal A, Stenberg T, Myrmel T, How O, Capriolo M, Frea S, Giustetto C, Scrocco C, Benedetto S, Grosso Marra W, Morello M, Gaita F, Garcia-Gonzalez P, Cozar-Santiago P, Chacon-Hernandez N, Ferrando-Beltran M, Fabregat-Andres O, De La Espriella-Juan R, Fontane-Martinez C, Jurado-Sanchez R, Morell-Cabedo S, Ridocci-Soriano F, Mihaila S, Piasentini E, Muraru D, Peluso D, Casablanca S, Puma L, Naso P, Iliceto S, Vinereanu D, Badano L, Tarzia P, Villano A, Figliozzi S, Russo G, Parrinello R, Lamendola P, Sestito A, Lanza G, Crea F, Sulemane S, Panoulas V, Bratsas A, Frankel A, Nihoyannopoulos P, Dores H, Andrade M, Almeida M, Goncalves P, Branco P, Gaspar A, Gomes A, Horta E, Carvalho M, Mendes M, Yue W, Li X, Chen Y, Luo Y, Gu P, Yiu K, Siu C, Tse H, Cho E, Lee S, Hwang B, Kim D, Jang S, Jeon H, Youn H, Kim J. Poster session Thursday 12 December - PM: 12/12/2013, 14:00-18:00 * Location: Poster area. Eur Heart J Cardiovasc Imaging 2013. [DOI: 10.1093/ehjci/jet204] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
125
|
Hernández-Sánchez JE, Castillo E, Barbero JM, Lista F, Gonzalez J. Prediction of extracapsular disease with multiparametric magnetic resonance imaging in high risk localized prostate cancer patient. ARCH ESP UROL 2013; 66:956-966. [PMID: 24369190] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Abstract
OBJECTIVES To assess the usefulness of multiparametric magnetic resonance imaging (MRI) in the staging of patients with localized prostate cancer (PC) and high risk of extracapsular disease (ECD). METHODS Retrospective study including 30 patients with localized PC and high risk of ECD. Pathologist and radiologist established an ECD suspicion according to the evaluation of the prostatic biopsy specimens and the multiparametric MRI analysis, respectively. Radical prostatectomy (RP) specimen analysis was used as a definitive confirmatory reference. Kappa (k)test was used to assess the degree of consistency between the initial suspicion provided by both specialists and the reference RP specimen. RESULTS When the prostatic gland was analyzed as a single unit, the pathological evaluation of the biopsy specimens did not correctly detect the risk of ECD in 46.6% of the patients (14/30; 10 FN; k=-0.035, 95%CI [-0.29-0.36]), while multiparametric MRI did not do in 36% of the cases (11/30, 9 FP; k=0.27, 95%CI [-0.03-0.61]). Whereas, if each side of the prostate (i.e. right and left) was considered as an independent observation, the pathologist wrongly predicted the risk of ECD in 35% of the cases (21/60; 18 FN; k=0.19, 95%CI [-0.03-0.40]), while the radiologist erred only in 18.3% of the cases (11/60; 7 FN and 4 FP; k=0, 61, 95%CI [0.40-0.81]). CONCLUSIONS Data from our experience suggest an added value of multiparametric MRI in the clinical staging of localized PC in cases of high risk of ECD. Multiparametric MRI may be used as a helpful tool in the surgical planning and the decision-making process regarding the management of this entity.
Collapse
Affiliation(s)
- J E Hernández-Sánchez
- Servicio de Urologia.HospitalNuestra Señora de Sonsoles. Avila.Radiology Department. Hospital Universitario de Getafe. Madrid.Anatomical Pathologic Department. Hospital Universitario de Getafe. Getafe. Madrid. Urology Department. Hospital Universitario de Getafe. Getafe. Madrid. Universidad Europea de Madrid. Madrid. Urology Department. Hospital Central de la Cruz Roja San José y Santa Adela. Madrid. Spain
| | | | | | | | | |
Collapse
|
126
|
Liapikou A, Polverino E, Cilloniz C, Peyrani P, Ramirez J, Menendez R, Torres A, Nakamatsu R, Arnold F, Allen M, Broch G, Bordon J, Gross P, Weiss K, Legnani D, Bodi M, Porras J, Torres A, Lode H, Roig J, Benchetrit G, Gonzalez J, Videla A, Corral J, Martinez J, Rodriguez E, Rodriguez M, Victorio C, Levy G, Arteta F, Fuenzalida AD, Parada M, Luna J. A Worldwide Perspective of Nursing Home-Acquired Pneumonia Compared With Community-Acquired Pneumonia. Respir Care 2013; 59:1078-85. [DOI: 10.4187/respcare.02788] [Citation(s) in RCA: 37] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
127
|
Gonzalez J, Jaume J, Fàbrega E, Gispert M, Gil M, Oliver A, Llonch P, Guàrdia M, Realini C, Arnau J, Tibau J. Majorcan Black Pig as a traditional pork production system: Improvements in slaughterhouse procedures and elaboration of pork carpaccio as an alternative product. Meat Sci 2013; 95:727-32. [DOI: 10.1016/j.meatsci.2013.03.012] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2012] [Revised: 03/05/2013] [Accepted: 03/11/2013] [Indexed: 10/27/2022]
|
128
|
Torrente D, Avila MF, Cabezas R, Morales L, Gonzalez J, Samudio I, Barreto GE. Paracrine factors of human mesenchymal stem cells increase wound closure and reduce reactive oxygen species production in a traumatic brain injury in vitro model. Hum Exp Toxicol 2013; 33:673-84. [PMID: 24178889 DOI: 10.1177/0960327113509659] [Citation(s) in RCA: 46] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
Abstract
Traumatic brain injury (TBI) consists of a primary and a secondary insult characterized by a biochemical cascade that plays a crucial role in cell death in the brain. Despite the major improvements in the acute care of head injury victims, no effective strategies exist for preventing the secondary injury cascade. This lack of success might be due to that most treatments are aimed at targeting neuronal population, even if studies show that astrocytes play a key role after a brain damage. In this work, we propose a new model of in vitro traumatic brain-like injury and use paracrine factors released by human mesenchymal stem cells (hMSCs) as a neuroprotective strategy. Our results demonstrate that hMSC-conditioned medium increased wound closure and proliferation at 12 h and reduced superoxide production to control conditions. This was accompanied by changes in cell morphology and polarity index, as both parameters reflect the ability of cells to migrate toward the wound. These findings indicate that hMSC is an important regulator of oxidative stress production, enhances cells migration, and shall be considered as a useful neuroprotective approach for brain recovery following injury.
Collapse
Affiliation(s)
- D Torrente
- Departamento de Nutrición y Bioquímica, Facultad de Ciencias, Pontificia Universidad Javeriana, Bogotá DC, Colombia
| | - M F Avila
- Departamento de Nutrición y Bioquímica, Facultad de Ciencias, Pontificia Universidad Javeriana, Bogotá DC, Colombia
| | - R Cabezas
- Departamento de Nutrición y Bioquímica, Facultad de Ciencias, Pontificia Universidad Javeriana, Bogotá DC, Colombia
| | - L Morales
- Departamento de Nutrición y Bioquímica, Facultad de Ciencias, Pontificia Universidad Javeriana, Bogotá DC, Colombia
| | - J Gonzalez
- Departamento de Nutrición y Bioquímica, Facultad de Ciencias, Pontificia Universidad Javeriana, Bogotá DC, Colombia
| | - I Samudio
- Departamento de Nutrición y Bioquímica, Facultad de Ciencias, Pontificia Universidad Javeriana, Bogotá DC, Colombia
| | - G E Barreto
- Departamento de Nutrición y Bioquímica, Facultad de Ciencias, Pontificia Universidad Javeriana, Bogotá DC, Colombia
| |
Collapse
|
129
|
Thanh HN, Khairy P, Guerra P, Dubuc M, Talajic M, Thibault B, Rivard L, Roy D, Dyrda K, Andrade J, Maillet N, Gonzalez J, Macle L. Prospective Evaluation of a Novel Catheter Tracking System Aimed at Reducing Fluoroscopy Exposure: Preliminary Results of the Atrial Fibrillation Ablation Cohort. Can J Cardiol 2013. [DOI: 10.1016/j.cjca.2013.07.288] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
130
|
Parke E, Hart J, Baldock D, Barchard K, Etcoff L, Allen D, Stolberg P, Nardi N, Cohen J, Jones W, Loe S, Etcoff L, Delgaty L, Tan A, Bunner M, Delgaty L, Tan A, Bunner M, Tan A, Delgaty L, Bunner M, Tan A, Delgaty L, Bunner M, Goodman G, Kim W, Nolty A, Marion S, Davis A, Finch W, Piehl J, Moss L, Nogin R, Dean R, Davis J, Lindstrom W, Poon M, Fonseca F, Bure-Reyes A, Stewart J, Golden C, Fonseca F, Bure-Reyes A, Stewart J, Golden C, Fields K, Hill B, Corley E, Russ K, Boettcher A, Musso M, Rohling M, Rowden A, Downing K, Benners M, Miller D, Maricle D, Dugbartey T, Anum A, Anderson J, Daniel M, Hoskins L, Gillis K, Khen S, Carter K, Ayers C, Neeland I, Cullum M, Weiner M, Rossetti H, Buddin W, Mahal S, Schroeder R, Baade L, Macaluso M, Phelps K, Evans C, Clark J, Vickery C, Chow J, Stokic D, Phelps K, Evans C, Watson S, Odom R, Clark J, Clark J, Odom R, Evans C, Vickery C, Thompson J, Noggle C, Kane C, Kecala N, Lane E, Raymond M, Woods S, Iudicello J, Dawson M, Ghias A, Choe M, Yudovin S, McArthur D, Asarnow R, Giza C, Babikian T, Tun S, O'Neil M, Ensley M, Storzbach D, Ellis R, O'Neil M, Carlson K, Storzbach D, Brenner L, Freeman M, Quinones A, Motu'apuaka M, Ensley M, Kansagara D, Brickell T, Grant I, Lange R, Kennedy J, Ivins B, Marshall K, Prokhorenko O, French L, Brickell T, Lange R, Bhagwat A, French L, Weber E, Nemeth D, Songy C, Gremillion A, Lange R, Brubacher J, Shewchuk J, Heran M, Jarrett M, Rauscher A, Iverson G, Woods S, Ukueberuwa D, Medaglia J, Hillary F, Meyer J, Vargas G, Rabinowitz A, Barwick F, Arnett P, Levan A, Gale S, Atkinson J, Boettcher A, Hill B, Rohling M, Stolberg P, Hart J, Allen D, Mayfield J, Ellis M, Marion SD, Houshyarnejad A, Grant I, Akarakian R, Kernan C, Babikian T, Asarnow R, Bens M, Fisher M, Garrett C, Vinogradov S, Walker K, Torstrick A, Uderman J, Wellington R, Zhao L, Fromm N, Dahdah M, Salisbury D, Monden K, Lande E, Wanlass R, Fong G, Smith K, Miele A, Novakovic-Agopian T, Chen A, Rome S, Rossi A, Abrams G, Murphy M, Binder D, Muir J, Carlin G, Loya F, Rabinovitz B, Bruhns M, Adler M, Schleicher-Dilks S, Messerly J, Babika C, Ukpabi C, Golden C, Schleicher-Dilks S, Coad S, Messerly J, Schaffer S, Babika C, Golden C, Cowad S, Paisley S, Fontanetta R, Messerly J, Golden C, Holder C, Kloezeman K, Henry B, Burns W, Patt V, Minassian A, Perry W, Cooper L, Allen D, Vogel S, Woolery H, Ciobanu C, Simone A, Bedard A, Olivier T, O'Neill S, Rajendran K, Halperin J, Rudd-Barnard A, Steenari M, Murry J, Le M, Becker T, Mucci G, Zupanc M, Shapiro E, Santos O, Cadavid N, Giese E, Londono N, Osmon D, Zamzow J, Culnan E, D'Argenio D, Mosti C, Spiers M, Schleicher-Dilks S, Kloss J, Curiel A, Miller K, Olmstead R, Gottuso A, Saucier C, Miller J, Dye R, Small G, Kent A, Andrews P, Puente N, Terry D, Faraco C, Brown C, Patel A, Siegel J, Miller L, Lee B, Joan M, Thaler N, Fontanetta R, Carla F, Allen D, Nguyen T, Glass L, Coles C, Julie K, May P, Sowell E, Jones K, Riley E, Demsky Y, Mattson S, Allart A, Freer B, Tiersky L, Sunderaraman P, Sylvester P, Ang J, Schultheis M, Newton S, Holland A, Burns K, Bunting J, Taylor J, Muetze H, Coe M, Harrison D, Putnam M, Tiersky L, Freer B, Holland A, Newton S, Sakamoto M, Bunting J, Taylor J, Coe M, Harrison D, Musso M, Hill B, Barker A, Pella R, Gouvier W, Davis J, Woods S, Wall J, Etherton J, Brand T, Hummer B, O'Shea C, Segovia J, Thomlinson S, Schulze E, Roskos P, Gfeller J, Loftis J, Fogel T, Barrera K, Sherzai A, Chappell A, Harrison A, Armstrong I, Flaro L, Pedersen H, Shultz LS, Roper B, Huckans M, Basso M, Silk-Eglit G, Stenclik J, Miele A, Lynch J, McCaffrey R, Silk-Eglit G, Stenclik J, Miele A, Lynch J, Musso M, McCaffrey R, Martin P, VonDran E, Baade L, Heinrichs R, Schroeder R, Hunter B, Calloway J, Rolin S, Akeson S, Westervelt H, Mohammed S, An K, Jeffay E, Zakzanis K, Lynch A, Drasnin D, Ikanga J, Graham O, Reid M, Cooper D, Long J, Lange R, Kennedy J, Hopewell C, Lukaszewska B, Pachalska M, Bidzan M, Lipowska M, McCutcheon L, Kaup A, Park J, Morgan E, Kenton J, Norman M, Martin P, Netson K, Woods S, Smith M, Paulsen J, Hahn-Ketter A, Paxton J, Fink J, Kelley K, Lee R, Pliskin N, Segala L, Vasilev G, Bozgunov K, Naslednikova R, Raynov I, Gonzalez R, Vassileva J, Bonilla X, Fedio A, Johnson K, Sexton J, Blackstone K, Weber E, Moore D, Grant I, Woods S, Pimental P, Welch M, Ring M, Stranks E, Crowe S, Jaehnert S, Ellis C, Prince C, Wheaton V, Schwartz D, Loftis J, Fuller B, Hoffman W, Huckans M, Turecka S, McKeever J, Morse C, Schultheis M, Dinishak D, Dasher N, Vik P, Hachey D, Bowman B, Van Ness E, Williams C, Zamzow J, Sunderaraman P, Kloss J, Spiers M, Swirsky-Sacchetti T, Alhassoon O, Taylor M, Sorg S, Schweinsburg B, Stricker N, Kimmel C, Grant I, Alhassoon O, Taylor M, Sorg S, Schweinsburg B, Stephan R, Stricker N, Grant I, Hertza J, Tyson K, Northington S, Loughan A, Perna R, Davis A, Collier M, Schroeder R, Buddin W, Schroeder R, Moore C, Andrew W, Ghelani A, Kim J, Curri M, Patel S, Denney D, Taylor S, Huberman S, Greenberg B, Lacritz L, Brown D, Hughes S, Greenberg B, Lacritz L, Vargas V, Upshaw N, Whigham K, Peery S, Casto B, Barker L, Otero T, La D, Nunan-Saah J, Phoong M, Gill S, Melville T, Harley A, Gomez R, Adler M, Tsou J, Schleicher-Dilks S, Golden C, Tsou J, Schleicher-Dilks S, Adler M, Golden C, Cowad S, Link J, Barker T, Gulliver K, Golden C, Young K, Moses J, Lum J, Vik P, Legarreta M, Van Ness E, Williams C, Dasher N, Williams C, Vik P, Dasher N, Van Ness E, Bowman B, Nakhutina L, Margolis S, Baek R, Gonzalez J, Hill F, England H, Horne-Moyer L, Stringer A, DeFilippis N, Lyon A, Giovannetti T, Fanning M, Heverly-Fitt S, Stambrook E, Price C, Selnes O, Floyd T, Vogt E, Thiruselvam I, Quasney E, Hoelzle J, Grant N, Moses J, Matevosyan A, Delano-Wood L, Alhassoon O, Hanson K, Lanni E, Luc N, Kim R, Schiehser D, Benners M, Downing K, Rowden A, Miller D, Maricle D, Kaminetskaya M, Moses J, Tai C, Kaminetskaya M, Melville T, Poole J, Scott R, Hays F, Walsh B, Mihailescu C, Douangratdy M, Scott B, Draffkorn C, Andrews P, Schmitt A, Waksmunski C, Brady K, Andrews A, Golden C, Olivier T, Espinoza K, Sterk V, Spengler K, Golden C, Olivier T, Spengler K, Sterk V, Espinoza K, Golden C, Gross J, DeFilippis N, Neiman-Kimel J, Romers C, Isaacs C, Soper H, Sordahl J, Tai C, Moses J, D'Orio V, Glukhovsky L, Beier M, Shuman M, Spat J, Foley F, Guatney L, Bott N, Moses J, Miranda C, Renteria MA, Rosario A, Sheynin J, Fuentes A, Byrd D, Mindt MR, Batchelor E, Meyers J, Patt V, Thomas M, Minassian A, Geyer M, Brown G, Perry W, Smith C, Kiefel J, Rooney A, Gouaux B, Ellis R, Grant I, Moore D, Graefe A, Wyman-Chick K, Daniel M, Beene K, Jaehnert S, Choi A, Moses J, Iudicello J, Henry B, Minassian A, Perry W, Marquine M, Morgan E, Letendre S, Ellis R, Woods S, Grant I, Heaton R, Constantine K, Fine J, Palewjala M, Macher R, Guatney L, Earleywine M, Draffkorn C, Scott B, Andrews P, Schmitt A, Dudley M, Silk-Eglit G, Stenclik J, Miele A, Lynch J, McCaffrey R, Scharaga E, Gomes W, McGinley J, Miles-Mason E, Colvin M, Carrion L, Romers C, Soper H, Zec R, Kohlrus S, Fritz S, Robbs R, Ala T, Zec R, Fritz S, Kohlrus S, Robbs R, Ala T, Edwards M, Hall J, O'Bryant S, Miller J, Dye R, Miller K, Baerresen K, Small G, Moskowitz J, Puente A, Ahmed F, Faraco C, Brown C, Evans S, Chu K, Miller L, Young-Bernier M, Tanguay A, Tremblay F, Davidson P, Duda B, Puente A, Terry D, Kent A, Patel A, Miller L, Junod A, Marion SD, Harrington M, Fonteh A, Gurnani A, John S, Gavett B, Diaz-Santos M, Mauro S, Beaute J, Cronin-Golomb A, Fazeli P, Gouaux B, Rosario D, Heaton R, Moore D, Puente A, Lindbergh C, Chu K, Evans S, Terry D, Duda B, Mackillop J, Miller S, Greco S, Klimik L, Cohen J, Robbins J, Lashley L, Schleicher-Dilks S, Golden C, Kunkes I, Culotta V, Kunkes I, Griffits K, Loughan A, Perna R, Hertza J, Cohen M, Northington S, Tyson K, Musielak K, Fine J, Kaczorowski J, Doty N, Braaten E, Shah S, Nemanim N, Singer E, Hinkin C, Levine A, Gold A, Evankovich K, Lotze T, Yoshida H, O'Bryan S, Roberg B, Glusman M, Ness A, Thelen J, Wilson L, Feaster T, Bruce J, Lobue C, Brown D, Hughes S, Greenberg B, Lacritz L, Bristow-Murray B, Andrews A, Bermudez C, Golden C, Moore R, Pulver A, Patterson T, Bowie C, Harvey P, Jeste D, Mausbach B, Wingo J, Fink J, Lee R, Pliskin N, Legenkaya A, Henry B, Minassian A, Perry W, McKeever J, Morse C, Thomas F, Schultheis M, Ruocco A, Daros A, Gill S, Grimm D, Saini G, Relova R, Hoblyn J, Lee T, Stasio C, Mahncke H, Drag L, Grimm D, Gill S, Saini G, Relova R, Hoblyn J, Lee T, Stasio C, Mahncke H, Drag L, Verbiest R, Ringdahl E, Thaler N, Sutton G, Vogel S, Reyes A, Ringdahl E, Vogel S, Freeman A, Call E, Allen D, March E, Salzberg M, Vogel S, Ringdahl E, Freeman A, Dadis F, Allen D, Sisk S, Ringdahl E, Vogel S, Freeman A, Allen D, DiGangi J, Silva L, Pliskin N, Thieme B, Daniel M, Jaehnert S, Noggle C, Thompson J, Kecala N, Lane E, Kane C, Noggle C, Thompson J, Lane E, Kecala N, Kane C, Palmer G, Happe M, Paxson J, Jurek B, Graca J, Olson S, Melville T, Harley A, La D, Phoong M, Gill S, Jocson VA, Nunan-Saah J, Keller J, Gomez R, Melville T, Kaminetskaya M, Poole J, Vernon A, Van Vleet T, DeGutis J, Chen A, Marini C, Dabit S, Gallegos J, Zomet A, Merzenich M, Thaler N, Linck J, Heyanka D, Pastorek N, Miller B, Romesser J, Sim A, Allen D, Zimmer A, Marcinak J, Hibyan S, Webbe F, Rainwater B, Francis J, Baum L, Sautter S, Donders J, Hui E, Barnes K, Walls G, Erikson S, Bailie J, Schwab K, Ivins B, Boyd C, Neff J, Cole W, Lewis S, Bailie J, Schwab K, Ivins B, Boyd C, Neff J, Cole W, Lewis S, Ramirez C, Oganes M, Gold S, Tanner S, Pina D, Merritt V, Arnett P, Heyanka D, Linck J, Thaler N, Pastorek N, Miller B, Romesser J, Sim A, Parks A, Roskos P, Gfeller J, Clark A, Isham K, Carter J, McLeod J, Romero R, Dahdah M, Barisa M, Schmidt K, Barnes S, Dubiel R, Dunklin C, Harper C, Callender L, Wilson A, Diaz-Arrastia R, Shafi S, Jacquin K, Bolshin L, Jacquin K, Romers C, Gutierrez E, Messerly J, Tsou J, Adler M, Golden C, Harmell A, Mausbach B, Moore R, Depp C, Jeste D, Palmer B, Hoadley R, Hill B, Rohling M, Mahdavi S, Fine J, daCruz K, Dinishak D, Richardson G, Vertinski M, Allen D, Mayfield J, Margolis S, Miele A, Rabinovitz B, Schaffer S, Kline J, Boettcher A, Hill B, Hoadley R, Rohling M, Eichstaedt K, Vale F, Benbadis S, Bozorg A, Rodgers-Neame N, Rinehardt E, Mattingly M, Schoenberg M, Fares R, Fares R, Carrasco R, Grups J, Evans B, Simco E, Mittenberg W, Carrasco R, Grups J, Evans B, Simco E, Mittenberg W, Rach A, Baughman B, Young C, Bene E, Irwin C, Li Y, Poulin R, Jerram M, Susmaras T, Gansler D, Ashendorf L, Miarmi L, Fazio R, Cantor J, Fernandez A, Godoy-Garcete G, Marchetti P, Harrison A, Armstrong I, Harrison L, Iverson G, Brinckman D, Ayaz H, Schultheis M, Heinly M, Vitelli K, Russler K, Sanchez I, Jones W, Loe S, Raines T, Hart J, Bene E, Li Y, Irwin C, Baughman B, Rach A, Bravo J, Schilling B, Weiss L, Lange R, Shewchuk J, Heran M, Rauscher A, Jarrett M, Brubacher J, Iverson G, Zink D, Barney S, Gilbert G, Allen D, Martin P, Schroeder R, Klas P, Jeffay E, Zakzanis K, Iverson G, Lanting S, Saffer B, Koehle M, Palmer B, Barrio C, Vergara R, Muniz M, Pinto L, Jeste D, Stenclik J, Lynch J, McCaffrey R, Shultz LS, Pedersen H, Roper B, Crouse E, Crucian G, Dezhkam N, Mulligan K, Singer R, Psihogios A, Davis A, Stephens B, Love C, Mulligan K, Webbe F, West S, McCue R, Goldin Y, Cicerone K, Ruchinskas R, Seidl JT, Massman P, Tam J, Schmitter-Edgecombe M, Baerresen K, Hanson E, Miller K, Miller J, Yeh D, Kim J, Ercoli L, Siddarth P, Small G, Noback M, Noback M, Baldock D, Mahmoud S, Munic-Miller D, Bonner-Jackson A, Banks S, Rabin L, Emerson J, Smith C, Roberts R, Hass S, Duhig A, Pankratz V, Petersen R, Leibson C, Harley A, Melville T, Phoong M, Gill S, Nunan-Saah J, La D, Gomez R, Lindbergh C, Puente A, Gray J, Chu K, Evans S, Sweet L, MacKillop J, Miller L, McAlister C, Schmitter-Edgecombe M, Baldassarre M, Kamm J, Wolff D, Dombrowski C, Bullard S, Edwards M, Hall J, Parsons T, O'Bryant S, Lawson R, Papadakis A, Higginson C, Barnett J, Wills M, Strang J, Dominska A, Wallace G, Kenworthy L, Bott N, Kletter H, Carrion V, Ward C, Getz G, Peer J, Baum C, Edner B, Mannarino A, Casnar C, Janke K, van der Fluit F, Natalie B, Haberman D, Solomon M, Hunter S, Klein-Tasman B, Starza-Smith A, Talbot E, Hart A, Hall M, Baker J, Kral M, Lally M, Zisk A, Lo T, Ross P, Cuevas M, Patel S, Lebby P, Mouanoutoua A, Harrison J, Pollock M, Mathiowetz C, Romero R, Boys C, Vekaria P, Vasserman M, MacAllister W, Stevens S, Van Hecke A, Carson A, Karst J, Schohl K, Dolan B, McKindles R, Remel R, Reveles A, Fritz N, McDonald G, Wasisco J, Kahne J, Hertza J, Tyson K, Northington S, Loughan A, Perna R, Newman A, Garmoe W, Clark J, Loughan A, Perna R, Hertza J, Cohen M, Northington S, Tyson K, Whithers K, Puente A, Dedmon A, Capps J, Lindsey H, Francis M, Weigand L, Steed A, Puente A, Edmed S, Sullivan K, Puente A, Lindsey H, Dedmon A, Capps J, Whithers K, Weigand L, Steed A, Kark S, Lafleche G, Brown T, Bogdanova Y, Strongin E, Spickler C, Drasnin D, Strongin C, Poreh A, Houshyarnejad A, Ellis M, Babikian T, Kernan C, Asarnow R, Didehbani N, Cullum M, Loneman L, Mansinghani S, Hart J, Fischer J. POSTER SESSIONS SCHEDULE. Arch Clin Neuropsychol 2013. [DOI: 10.1093/arclin/act054] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
131
|
Orenes-Pinero E, Hernandez-Romero D, Climent V, Caballero L, Garcia-Honrubia A, Garrigos-Gomez N, Feliu E, Gonzalez J, Valdes M, Marin F. Combination of two polymorphisms in non-sarcomeric genes and late gadolinium enhancement in hypertrophic cardiomyopathy. Eur Heart J 2013. [DOI: 10.1093/eurheartj/eht309.p4244] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
132
|
Galizio N, Martinenghi N, Fernandez A, Palazzo A, Gonzalez J, Casabe H, Fraguas H, Renedo F, Carnero G, Favaloro L. Hypertrophic cardiomyopathy. Long term outcomes of patients with implantable cardioverter defibrillator in a single centre. Eur Heart J 2013. [DOI: 10.1093/eurheartj/eht308.866] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
133
|
Sutachan JJ, Casas Z, Albarracin SL, Stab BR, Samudio I, Gonzalez J, Morales L, Barreto GE. Cellular and molecular mechanisms of antioxidants in Parkinson's disease. Nutr Neurosci 2013; 15:120-6. [DOI: 10.1179/1476830511y.0000000033] [Citation(s) in RCA: 82] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
|
134
|
Albarracin SL, Stab B, Casas Z, Sutachan JJ, Samudio I, Gonzalez J, Gonzalo L, Capani F, Morales L, Barreto GE. Effects of natural antioxidants in neurodegenerative disease. Nutr Neurosci 2013; 15:1-9. [DOI: 10.1179/1476830511y.0000000028] [Citation(s) in RCA: 178] [Impact Index Per Article: 16.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
|
135
|
Gonzalez J, Saha S, Peeva E. Prolactin rescues and primes autoreactive B cells directly and indirectly through dendritic cells in B6.Sle3 mice. Clin Exp Immunol 2013; 172:311-20. [PMID: 23574327 DOI: 10.1111/cei.12050] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 12/06/2012] [Indexed: 11/29/2022] Open
Abstract
The lupus susceptibility interval Sle3/5 confers responsiveness to prolactin in C57BL/6 (B6) mice and hyperprolactinaemia induces a lupus-like phenotype in B6.Sel3/5 mice. In this study, the immunostimulatory effects of prolactin in B6 mice containing the Sle3 portion of the Sel3/5 interval (B6.Sle3 mice) were dissected. Because of the Sle3 interval's involvement in activation of myeloid cells, the effect of dendritic cells (DCs) from prolactin-treated B6.Sle3 mice on the phenotype of B6 mice was also evaluated. B cells from prolactin-treated B6 and B6.Sle3 mice and from B6 recipients of prolactin-modulated DCs from B6.Sle3 mice were tested for DNA-reactivity and resistance to B cell receptor (BCR)-mediated apoptosis. The expression of co-stimulatory molecules on lymphocytes and myeloid cells was also evaluated. In prolactin-treated B6.Sle3 mice, transitional type 2 B cells increased while type 1 B cells decreased as a consequence of prolactin-induced resistance to BCR-mediated apoptosis leading to the survival of DNA-reactive B cells. Follicular B cells from prolactin-treated mice expressed increased levels of CD40, B7·2 and IA(b), and DCs and monocytes had higher levels of CD44 and B7·2 than placebo-treated mice. Adoptive transfer of DCs from prolactin-treated B6.Sle3 mice to B6 recipients demonstrated the intrinsic ability of prolactin-modulated DCs to induce a development of lupus-like characteristics in B6 mice. Based on these results, prolactin accelerates the breakdown of immune tolerance in B6.Sle3 mice by promoting the survival, maturation and activation of autoreactive B cells, DCs and macrophages.
Collapse
Affiliation(s)
- J Gonzalez
- Department of Medicine, Albert Einstein College of Medicine, Bronx, NY, USA
| | | | | |
Collapse
|
136
|
Gonzalez J, Lopez J, Azinovic I, Forastero C, Casal M, Silvestre E, Osuna P, Rua C, Rodríguez-palacios J, Jaen J. Systematic and random patient set-up errors in a single-radiation center. Rep Pract Oncol Radiother 2013. [DOI: 10.1016/j.rpor.2013.03.398] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022] Open
|
137
|
Cabezas R, Fidel M, Torrente D, Santos El-Bach R, Morales L, Gonzalez J, E. G. Astrocytes Role in Parkinson: A Double-Edged Sword. NEURODEGENER DIS 2013. [DOI: 10.5772/54305] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022] Open
|
138
|
Gonzalez J, Jaramillo N, Vargas A, Pineda A, Roncancio G. P67 24H-CEFUROXIME CAN BE SUFFICIENT FOR ANTIMICROBIAL PROPHYLAXIS IN CARDIAC SURGERY. Int J Antimicrob Agents 2013. [DOI: 10.1016/s0924-8579(13)70091-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
139
|
Avila MF, Cabezas R, Torrente D, Gonzalez J, Morales L, Alvarez L, Capani F, Barreto GE. Novel interactions of GRP78: UPR and estrogen responses in the brain. Cell Biol Int 2013; 37:521-32. [DOI: 10.1002/cbin.10058] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2012] [Accepted: 01/22/2013] [Indexed: 12/21/2022]
Affiliation(s)
- Marco Fidel Avila
- Departamento de Nutrición y Bioquímica; Facultad de Ciencias, Pontificia Universidad Javeriana; Bogotá D.C., Colombia
| | - Ricardo Cabezas
- Departamento de Nutrición y Bioquímica; Facultad de Ciencias, Pontificia Universidad Javeriana; Bogotá D.C., Colombia
| | - Daniel Torrente
- Departamento de Nutrición y Bioquímica; Facultad de Ciencias, Pontificia Universidad Javeriana; Bogotá D.C., Colombia
| | - Janneth Gonzalez
- Departamento de Nutrición y Bioquímica; Facultad de Ciencias, Pontificia Universidad Javeriana; Bogotá D.C., Colombia
| | - Ludis Morales
- Departamento de Nutrición y Bioquímica; Facultad de Ciencias, Pontificia Universidad Javeriana; Bogotá D.C., Colombia
| | - Lisandro Alvarez
- Laboratorio de Citoarquitectura y Plasticidad Neuronal, Instituto de Investigaciones Cardiológicas Prof. Dr. Alberto C. Taquini (ININCA), Facultad de Medicina, UBA-CONICET; Marcelo T. de Alvear 2270, C1122AAJ Buenos Aires; Argentina
| | - Francisco Capani
- Laboratorio de Citoarquitectura y Plasticidad Neuronal, Instituto de Investigaciones Cardiológicas Prof. Dr. Alberto C. Taquini (ININCA), Facultad de Medicina, UBA-CONICET; Marcelo T. de Alvear 2270, C1122AAJ Buenos Aires; Argentina
| | - George E. Barreto
- Departamento de Nutrición y Bioquímica; Facultad de Ciencias, Pontificia Universidad Javeriana; Bogotá D.C., Colombia
| |
Collapse
|
140
|
Chizhik A, Blanco J, Ipatov M, Zhukova V, Gonzalez J, Zhukov A. Domain walls collision in Fe-rich and Co-rich glass covered microwires. EPJ Web of Conferences 2013. [DOI: 10.1051/epjconf/20134017004] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
141
|
|
142
|
Gucalp A, Tolaney S, Isakoff SJ, Ingle J, Liu MC, Carey L, Blackwell KL, Rugo H, Nabell L, Forero A, Stearns V, Momen L, Gonzalez J, Akhtar A, Giri DD, Patil S, Feigin KN, Hudis CA, Traina TA. Abstract P6-05-02: Endocrine biomarkers in response to AR-inhibition with bicalutamide for the treatment of AR(+), ER/PR(−) metastatic breast cancer (MBC) (TBCRC011). Cancer Res 2012. [DOI: 10.1158/0008-5472.sabcs12-p6-05-02] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Our group and others have identified a subset of ER/PR(−) breast cancers characterized by expression of the androgen receptor (AR) and androgen-dependent growth (Doane 2006). We conducted a proof-of-concept multicenter phase II study to test the efficacy of the AR-antagonist, bicalutamide for the treatment of AR(+) ER/PR(−) MBC (NCT00468715). Results of the primary endpoint, clinical benefit rate (CBR), were presented at ASCO (Gucalp 2012). Data for the impact of bicalutamide on circulating hormone levels in women are limited. Elevations in serum testosterone (T) and estradiol (E) have been observed for men treated with bicalutamide. We hypothesized comparable patterns of change in circulating endocrine markers in response to bicalutamide for women with MBC.
Methods: Patients (pts) with AR(+) (IHC ≥10%), ER/PR(−) (IHC <10%) MBC were eligible for treatment (tx) if ECOG performance status ≤2 and normal organ function regardless of menopausal status. There was no limit to prior tx except prior trastuzumab required if HER2(+). Tx consisted of bicalutamide 150mg orally daily in 28-day cycles (C). Toxicity assessed q4 weeks, response q12wks. Primary endpoint was CBR. Peripheral blood was collected for total and free T, E and sex hormone binding globulin (SHBG) at baseline, start of C2 (C2) and at end of study (EOS). Standard institutional assays were used. A Wilcoxon signed-rank test was done to compare baseline to C2 and EOS values.
Results: 26 patients with AR(+) ER/PR(−) MBC were treated on study. Evaluable number (n) of pts at baseline, C2 and EOS are 26, 26 and 19 respectively. Two pts remain on study. Menopausal status: pre=2, post=24. Baseline median total and free T and estradiol were consistent with expected norms, however a wide range was observed (Table). There were no significant differences observed for median free T, total T, E or SHBG between baseline and C2 or baseline and EOS. Changes in hormone levels could not be stratified by menopausal status or response to bicalutamide given small sample size. Given the wide range of baseline values, we examined the percent change for each endocrine biomarker from baseline to C2 and EOS. As shown in the Table, there was no difference in median percent change observed across time points for each biomarker.
Conclusions: No discernible patterns of change in T, E or SHBG were observed in response to bicalutamide therapy when given to women for the treatment of AR(+), ER/PR(−) MBC. These circulating hormones require further evaluation for use as a pharmacodynamic marker.
Citation Information: Cancer Res 2012;72(24 Suppl):Abstract nr P6-05-02.
Collapse
Affiliation(s)
- A Gucalp
- Memorial Sloan-Kettering Cancer Center; Dana Farber/Harvard Cancer Center; Mayo Clinic Cancer Center; Lombardi Comprehensive Cancer Center at Georgetown University; University of North Carolina Lineberger Cancer Center; University of California San Francisco Comprehensive Cancer Center; Duke University Medical Cancer Center; University of Alabama Comprehensive Cancer Center; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
| | - S Tolaney
- Memorial Sloan-Kettering Cancer Center; Dana Farber/Harvard Cancer Center; Mayo Clinic Cancer Center; Lombardi Comprehensive Cancer Center at Georgetown University; University of North Carolina Lineberger Cancer Center; University of California San Francisco Comprehensive Cancer Center; Duke University Medical Cancer Center; University of Alabama Comprehensive Cancer Center; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
| | - SJ Isakoff
- Memorial Sloan-Kettering Cancer Center; Dana Farber/Harvard Cancer Center; Mayo Clinic Cancer Center; Lombardi Comprehensive Cancer Center at Georgetown University; University of North Carolina Lineberger Cancer Center; University of California San Francisco Comprehensive Cancer Center; Duke University Medical Cancer Center; University of Alabama Comprehensive Cancer Center; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
| | - J Ingle
- Memorial Sloan-Kettering Cancer Center; Dana Farber/Harvard Cancer Center; Mayo Clinic Cancer Center; Lombardi Comprehensive Cancer Center at Georgetown University; University of North Carolina Lineberger Cancer Center; University of California San Francisco Comprehensive Cancer Center; Duke University Medical Cancer Center; University of Alabama Comprehensive Cancer Center; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
| | - MC Liu
- Memorial Sloan-Kettering Cancer Center; Dana Farber/Harvard Cancer Center; Mayo Clinic Cancer Center; Lombardi Comprehensive Cancer Center at Georgetown University; University of North Carolina Lineberger Cancer Center; University of California San Francisco Comprehensive Cancer Center; Duke University Medical Cancer Center; University of Alabama Comprehensive Cancer Center; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
| | - L Carey
- Memorial Sloan-Kettering Cancer Center; Dana Farber/Harvard Cancer Center; Mayo Clinic Cancer Center; Lombardi Comprehensive Cancer Center at Georgetown University; University of North Carolina Lineberger Cancer Center; University of California San Francisco Comprehensive Cancer Center; Duke University Medical Cancer Center; University of Alabama Comprehensive Cancer Center; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
| | - KL Blackwell
- Memorial Sloan-Kettering Cancer Center; Dana Farber/Harvard Cancer Center; Mayo Clinic Cancer Center; Lombardi Comprehensive Cancer Center at Georgetown University; University of North Carolina Lineberger Cancer Center; University of California San Francisco Comprehensive Cancer Center; Duke University Medical Cancer Center; University of Alabama Comprehensive Cancer Center; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
| | - H Rugo
- Memorial Sloan-Kettering Cancer Center; Dana Farber/Harvard Cancer Center; Mayo Clinic Cancer Center; Lombardi Comprehensive Cancer Center at Georgetown University; University of North Carolina Lineberger Cancer Center; University of California San Francisco Comprehensive Cancer Center; Duke University Medical Cancer Center; University of Alabama Comprehensive Cancer Center; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
| | - L Nabell
- Memorial Sloan-Kettering Cancer Center; Dana Farber/Harvard Cancer Center; Mayo Clinic Cancer Center; Lombardi Comprehensive Cancer Center at Georgetown University; University of North Carolina Lineberger Cancer Center; University of California San Francisco Comprehensive Cancer Center; Duke University Medical Cancer Center; University of Alabama Comprehensive Cancer Center; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
| | - A Forero
- Memorial Sloan-Kettering Cancer Center; Dana Farber/Harvard Cancer Center; Mayo Clinic Cancer Center; Lombardi Comprehensive Cancer Center at Georgetown University; University of North Carolina Lineberger Cancer Center; University of California San Francisco Comprehensive Cancer Center; Duke University Medical Cancer Center; University of Alabama Comprehensive Cancer Center; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
| | - V Stearns
- Memorial Sloan-Kettering Cancer Center; Dana Farber/Harvard Cancer Center; Mayo Clinic Cancer Center; Lombardi Comprehensive Cancer Center at Georgetown University; University of North Carolina Lineberger Cancer Center; University of California San Francisco Comprehensive Cancer Center; Duke University Medical Cancer Center; University of Alabama Comprehensive Cancer Center; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
| | - L Momen
- Memorial Sloan-Kettering Cancer Center; Dana Farber/Harvard Cancer Center; Mayo Clinic Cancer Center; Lombardi Comprehensive Cancer Center at Georgetown University; University of North Carolina Lineberger Cancer Center; University of California San Francisco Comprehensive Cancer Center; Duke University Medical Cancer Center; University of Alabama Comprehensive Cancer Center; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
| | - J Gonzalez
- Memorial Sloan-Kettering Cancer Center; Dana Farber/Harvard Cancer Center; Mayo Clinic Cancer Center; Lombardi Comprehensive Cancer Center at Georgetown University; University of North Carolina Lineberger Cancer Center; University of California San Francisco Comprehensive Cancer Center; Duke University Medical Cancer Center; University of Alabama Comprehensive Cancer Center; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
| | - A Akhtar
- Memorial Sloan-Kettering Cancer Center; Dana Farber/Harvard Cancer Center; Mayo Clinic Cancer Center; Lombardi Comprehensive Cancer Center at Georgetown University; University of North Carolina Lineberger Cancer Center; University of California San Francisco Comprehensive Cancer Center; Duke University Medical Cancer Center; University of Alabama Comprehensive Cancer Center; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
| | - DD Giri
- Memorial Sloan-Kettering Cancer Center; Dana Farber/Harvard Cancer Center; Mayo Clinic Cancer Center; Lombardi Comprehensive Cancer Center at Georgetown University; University of North Carolina Lineberger Cancer Center; University of California San Francisco Comprehensive Cancer Center; Duke University Medical Cancer Center; University of Alabama Comprehensive Cancer Center; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
| | - S Patil
- Memorial Sloan-Kettering Cancer Center; Dana Farber/Harvard Cancer Center; Mayo Clinic Cancer Center; Lombardi Comprehensive Cancer Center at Georgetown University; University of North Carolina Lineberger Cancer Center; University of California San Francisco Comprehensive Cancer Center; Duke University Medical Cancer Center; University of Alabama Comprehensive Cancer Center; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
| | - KN Feigin
- Memorial Sloan-Kettering Cancer Center; Dana Farber/Harvard Cancer Center; Mayo Clinic Cancer Center; Lombardi Comprehensive Cancer Center at Georgetown University; University of North Carolina Lineberger Cancer Center; University of California San Francisco Comprehensive Cancer Center; Duke University Medical Cancer Center; University of Alabama Comprehensive Cancer Center; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
| | - CA Hudis
- Memorial Sloan-Kettering Cancer Center; Dana Farber/Harvard Cancer Center; Mayo Clinic Cancer Center; Lombardi Comprehensive Cancer Center at Georgetown University; University of North Carolina Lineberger Cancer Center; University of California San Francisco Comprehensive Cancer Center; Duke University Medical Cancer Center; University of Alabama Comprehensive Cancer Center; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
| | - TA Traina
- Memorial Sloan-Kettering Cancer Center; Dana Farber/Harvard Cancer Center; Mayo Clinic Cancer Center; Lombardi Comprehensive Cancer Center at Georgetown University; University of North Carolina Lineberger Cancer Center; University of California San Francisco Comprehensive Cancer Center; Duke University Medical Cancer Center; University of Alabama Comprehensive Cancer Center; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
| |
Collapse
|
143
|
Traina TA, Hudis C, Seidman A, Gajria D, Gonzalez J, Anthony SP, Smith DA, Chandler JC, Jac J, Youssoufian H, Korth CC, Barrett JA, Sun L, Norton L. Abstract P6-11-10: IBL2001: Phase I/II study of a novel dose-dense schedule of oral indibulin for the treatment of metastastic breast cancer. Cancer Res 2012. [DOI: 10.1158/0008-5472.sabcs12-p6-11-10] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Indibulin (ZI0-301) is a novel, oral, synthetic small molecule microtubule inhibitor which binds tubulin at a different site than taxanes and vinca alkaloids. Preclinical data demonstrate indibulin does not interact with acetylated (neuronal) tubulins and in clinical studies has not exhibited the neurotoxicity associated with other tubulin binders. Indibulin has potent antitumor activity in human cancer cell lines, including multidrug-, taxane-, and vinblastine-resistant. Norton-Simon modeling based on cell line data suggested that dose dense (dd) administration could optimize efficacy while limiting toxicity.
Methods: Eligible patients (pts) have metastatic or unresectable locally advanced breast cancer, ECOG performance status ≤ 2, adequate organ function, measurable or nonmeasurable disease and any number of prior therapies. Uncontrolled gastrointestinal malabsorption syndrome and grade 2 or higher peripheral neuropathy are the principal exclusions. Adverse events (AEs) are graded by CTCAE v. 4.0. Objective disease status is evaluated according to RECIST 1.1. The primary objective of the phase (Ph) I portion of the study is to determine the maximum tolerated dose (MTD) of indibulin when given in dd fashion 5 days treatment, 9 days rest using standard 3+3 dose escalation schema.
The secondary objectives are to evaluate safety profile at various dosing levels, pharmacokinetics (PK) and preliminary activity of indibulin. Once the MTD is defined, a food effect cross- over group (N = 12) will be enrolled. Two groups of 6 pts each will be treated in either the fed or fasted state during the first cycle. A subgroup of 13 pts consisting of 12 pts from the food effect group plus the last pt from the MTD cohort will be evaluated for PFS at 4 months and will serve as the population for the first stage of a Simon two-stage design. If 4 or more out of 13 pts do not progress at 4 months, the Ph II portion of the study will be opened.
Results: Twenty one pts (20 F, 1 M) have been enrolled to cohorts 1 through 6 and the dose escalation is ongoing. Preliminary safety and efficacy data have been analyzed for 18 pts treated in cohorts 1 through 5 and are presented henceforth. No DLT has been observed and no MTD has been reached. Median age 58 years (32–81). PS 0=4, 1=12, 2=2. Median number of prior therapies 5 (1–12). Most frequent treatment-emergent AEs were: anorexia, constipation, cough, nausea (each in 39% pts); dyspnea (33%); fatigue, vomiting (each 28%). There were no related grade 3–4 AEs. PK analysis revealed that indibulin plasma exposures increased approximately dose proportionally from 25 to 200 mg with Cmax of 165 ± 89 ng/mL and AUC0-24 of 1411 ± 111 ng·h/mL at 200 mg. There were no objective responses. Stable disease was seen in 1 pt in the 150 mg cohort. Longest duration on-study was 4 months.
Conclusions: Oral indibulin was well tolerated in the doses up to 200 mg and the dose-proportional PK with lack of DLTs allows for further dose-escalation. Stable disease observed at sub-MTD dose may be a sign of activity in this heavily pre-treated population.
Citation Information: Cancer Res 2012;72(24 Suppl):Abstract nr P6-11-10.
Collapse
Affiliation(s)
- TA Traina
- Memorial Sloan-Kettering Cancer Center, New York, NY; Evergreen Hematology and Oncology, Spokane, WA; Compass Oncology, Vancouver, WA; The West Clinic, Memphis, TN; US Oncology Research, Woodlands, TX; ZIOPHARM Oncology, Inc., Boston, MA; Harmon Hill Consulting, New York, NY
| | - C Hudis
- Memorial Sloan-Kettering Cancer Center, New York, NY; Evergreen Hematology and Oncology, Spokane, WA; Compass Oncology, Vancouver, WA; The West Clinic, Memphis, TN; US Oncology Research, Woodlands, TX; ZIOPHARM Oncology, Inc., Boston, MA; Harmon Hill Consulting, New York, NY
| | - A Seidman
- Memorial Sloan-Kettering Cancer Center, New York, NY; Evergreen Hematology and Oncology, Spokane, WA; Compass Oncology, Vancouver, WA; The West Clinic, Memphis, TN; US Oncology Research, Woodlands, TX; ZIOPHARM Oncology, Inc., Boston, MA; Harmon Hill Consulting, New York, NY
| | - D Gajria
- Memorial Sloan-Kettering Cancer Center, New York, NY; Evergreen Hematology and Oncology, Spokane, WA; Compass Oncology, Vancouver, WA; The West Clinic, Memphis, TN; US Oncology Research, Woodlands, TX; ZIOPHARM Oncology, Inc., Boston, MA; Harmon Hill Consulting, New York, NY
| | - J Gonzalez
- Memorial Sloan-Kettering Cancer Center, New York, NY; Evergreen Hematology and Oncology, Spokane, WA; Compass Oncology, Vancouver, WA; The West Clinic, Memphis, TN; US Oncology Research, Woodlands, TX; ZIOPHARM Oncology, Inc., Boston, MA; Harmon Hill Consulting, New York, NY
| | - SP Anthony
- Memorial Sloan-Kettering Cancer Center, New York, NY; Evergreen Hematology and Oncology, Spokane, WA; Compass Oncology, Vancouver, WA; The West Clinic, Memphis, TN; US Oncology Research, Woodlands, TX; ZIOPHARM Oncology, Inc., Boston, MA; Harmon Hill Consulting, New York, NY
| | - DA Smith
- Memorial Sloan-Kettering Cancer Center, New York, NY; Evergreen Hematology and Oncology, Spokane, WA; Compass Oncology, Vancouver, WA; The West Clinic, Memphis, TN; US Oncology Research, Woodlands, TX; ZIOPHARM Oncology, Inc., Boston, MA; Harmon Hill Consulting, New York, NY
| | - JC Chandler
- Memorial Sloan-Kettering Cancer Center, New York, NY; Evergreen Hematology and Oncology, Spokane, WA; Compass Oncology, Vancouver, WA; The West Clinic, Memphis, TN; US Oncology Research, Woodlands, TX; ZIOPHARM Oncology, Inc., Boston, MA; Harmon Hill Consulting, New York, NY
| | - J Jac
- Memorial Sloan-Kettering Cancer Center, New York, NY; Evergreen Hematology and Oncology, Spokane, WA; Compass Oncology, Vancouver, WA; The West Clinic, Memphis, TN; US Oncology Research, Woodlands, TX; ZIOPHARM Oncology, Inc., Boston, MA; Harmon Hill Consulting, New York, NY
| | - H Youssoufian
- Memorial Sloan-Kettering Cancer Center, New York, NY; Evergreen Hematology and Oncology, Spokane, WA; Compass Oncology, Vancouver, WA; The West Clinic, Memphis, TN; US Oncology Research, Woodlands, TX; ZIOPHARM Oncology, Inc., Boston, MA; Harmon Hill Consulting, New York, NY
| | - CC Korth
- Memorial Sloan-Kettering Cancer Center, New York, NY; Evergreen Hematology and Oncology, Spokane, WA; Compass Oncology, Vancouver, WA; The West Clinic, Memphis, TN; US Oncology Research, Woodlands, TX; ZIOPHARM Oncology, Inc., Boston, MA; Harmon Hill Consulting, New York, NY
| | - JA Barrett
- Memorial Sloan-Kettering Cancer Center, New York, NY; Evergreen Hematology and Oncology, Spokane, WA; Compass Oncology, Vancouver, WA; The West Clinic, Memphis, TN; US Oncology Research, Woodlands, TX; ZIOPHARM Oncology, Inc., Boston, MA; Harmon Hill Consulting, New York, NY
| | - L Sun
- Memorial Sloan-Kettering Cancer Center, New York, NY; Evergreen Hematology and Oncology, Spokane, WA; Compass Oncology, Vancouver, WA; The West Clinic, Memphis, TN; US Oncology Research, Woodlands, TX; ZIOPHARM Oncology, Inc., Boston, MA; Harmon Hill Consulting, New York, NY
| | - L Norton
- Memorial Sloan-Kettering Cancer Center, New York, NY; Evergreen Hematology and Oncology, Spokane, WA; Compass Oncology, Vancouver, WA; The West Clinic, Memphis, TN; US Oncology Research, Woodlands, TX; ZIOPHARM Oncology, Inc., Boston, MA; Harmon Hill Consulting, New York, NY
| |
Collapse
|
144
|
Fanjul F, Riveiro-Barciela M, Gonzalez J, Delgado E, Murillas J, Payeras Cifré A, Falcó V, Riera M. Evaluation of progressive multifocal leukoencephalopathy treatments in a Spanish cohort of HIV-infected patients: do protease inhibitors improve survival regardless of central nervous system penetration-effectiveness (CPE) score? HIV Med 2012; 14:321-5. [PMID: 23217049 DOI: 10.1111/hiv.12008] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/29/2012] [Indexed: 11/26/2022]
Abstract
OBJECTIVES The aim of the study was to investigate whether survival after progressive multifocal leukoencephalopathy (PML) diagnosis in HIV-1-infected patients was associated with central nervous system penetration-effectiveness (CPE) score and the presence or absence of protease inhibitors in the treatment regimen. METHODS In the absence of treatments demonstrated to be effective for PML in HIV-1-infected patients and in the light of the controversy surrounding the use of CPE scores to make decisions on treatment after diagnosis, we determined whether there were differences in survival at 1 year depending on the type and characteristics of treatment. A multicentre retrospective observational study including three Spanish hospitals was carried out for the period from 1 January 1994 to 31 December 2009. Patients with a PML diagnosis were included in the study if they were symptomatic and met at least two of the following three criteria: (1) compatible radiological findings; (2) a positive polymerase chain reaction for John Cunningham virus (JCV) in the cerebrospinal fluid (CSF); (3) an absence of findings suggesting another infection in the central nervous system, after general CSF cultures for virus, bacteria and mycobacteria. RESULTS A total of 98 patients were included in the study; 24.5% were diagnosed in the period 1994-1999, 39.8% in 2000-2004 and 35.7% in 2005-2009. The median follow-up time was 363 days (interquartile range 108-1946 days). The median CD4 count was 76 cells/uL (interquartile range 30-166 cells/uL) and 62% of patients had an HIV viral load >50 HIV-1 RNA copies/ml. Thirty-eight per cent of patients received high-penetrance treatment, and 58% received treatment that included protease inhibitors. In the analysis of survival at 1 year, a higher CPE score did not result in an improvement in survival, but the presence of protease inhibitors in the regimen was associated with a statistically significant (P = 0.03) reduction in mortality (hazard ratio 0.40; 95% confidence interval 0.18-0.91). CONCLUSIONS We consider that the lower mortality observed in the protease inhibitor group may be clinically relevant, and, if this is the case, a treatment based on protease inhibitors may be indicated for patients diagnosed with PML.
Collapse
Affiliation(s)
- F Fanjul
- Department of Infectious Diseases, Hospital Universitario Son Espases, Carretera de Valldemosa SN, Palma de Mallorca, Illes Balears, Spain.
| | | | | | | | | | | | | | | |
Collapse
|
145
|
Perlick DA, Gonzalez J, Michael L, Huth M, Culver J, Kaczynski R, Calabrese J, Miklowitz DJ. Rumination, gender, and depressive symptoms associated with caregiving strain in bipolar disorder. Acta Psychiatr Scand 2012; 126:356-62. [PMID: 22607486 PMCID: PMC3870006 DOI: 10.1111/j.1600-0447.2012.01874.x] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
Abstract
OBJECTIVE To evaluate the associations between indices of caregiving strain, ruminative style, depressive symptoms, and gender among family members of patients with bipolar disorder. METHOD One hundred and fifty primary caregivers of patients enrolled in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) participated in a cross-sectional study to evaluate the role of ruminative style in maintaining depressive symptoms associated with caregiving strain. Patient lifetime diagnosis and current episode status were evaluated by the Affective Disorder Evaluation and the Clinical Monitoring Form. Caregivers were evaluated within 30 days of the patient on measures of family strain, depressive symptoms, and ruminative style. RESULTS Men and women did not differ on depression, caregiver strain, or ruminative style scores. Scores suggest an overall mild level of depression and moderate caregiver strain for the sample. Greater caregiver strain was significantly associated (P<0.05) with rumination and level of depressive symptoms, controlling for patient clinical status and demographic variables. Rumination reduced the apparent association between strain and depression by nearly half. Gender was not significantly associated with depression or rumination. CONCLUSION Rumination helps explain depressive symptoms experienced by both male and female caregivers of patients with bipolar disorder. Interventions for caregivers targeted at decreasing rumination should be considered.
Collapse
Affiliation(s)
- D. A. Perlick
- Department of Psychiatry, Mount Sinai School of Medicine, New York, NY,JJ Peters Department of Veterans Affairs Medical Center and VISN 3 Mental Illness, Research, Education and Clinical Center, Bronx, NY
| | - J. Gonzalez
- Department of Psychiatry, University of Texas Health Science Center, San Antonio, TX
| | - L. Michael
- Department of Psychiatry, Mount Sinai School of Medicine, New York, NY
| | - M. Huth
- Department of Psychology, Michigan State University, Lansing, MI
| | - J. Culver
- Department of Psychiatry, Stanford University School of Medicine, Palo Alto, CA
| | - R. Kaczynski
- Department of Psychiatry, Yale University School of Medicine, New Haven, CT
| | - J. Calabrese
- Department of Psychiatry, Case-Western Reserve University, Cleveland, OH
| | - D. J. Miklowitz
- Department of Psychology, University of California, Los Angeles, CA, USA
| |
Collapse
|
146
|
Molina A, Gonzalez J, Laborda E, Compton RG. Mass transport at electrodes of arbitrary geometry. Reversible charge transfer reactions in square wave voltammetry. RUSS J ELECTROCHEM+ 2012. [DOI: 10.1134/s1023193512060079] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
|
147
|
Yi Chun DX, Alexandre H, Edith B, Nacera O, Julie P, Chantal J, Eric R, Zhang X, Jin Y, Miravete M, Dissard R, Klein J, Gonzalez J, Caubet C, Pecher C, Pipy B, Bascands JL, Mercier-Bonin M, Schanstra J, Buffin-Meyer B, Claire R, Rigothier C, Richard D, Sebastien L, Moin S, Chantal B, Christian C, Jean R, Migliori M, Migliori M, Cantaluppi V, Mannari C, Medica D, Giovannini L, Panichi V, Goldwich A, Alexander S, Andre G, Amann K, Migliorini A, Sagrinati C, Angelotti ML, Mulay SR, Ronconi E, Peired A, Romagnani P, Anders HJ, Chiang WC, Lai CF, Peng WH, Wu CF, Chang FC, Chen YT, Lin SL, Chen YM, Wu KD, Lu KS, Tsai TJ, Virgine O, Qing Feng F, Zhang SY, Dominique D, Vincent A, Marina C, Philippe L, Georges G, Pawlak A, Sahali D, Matsumoto S, Kiyomoto H, Ichimura A, Dan T, Nakamichi T, Tsujita T, Akahori K, Ito S, Miyata T, Xie S, Zhang B, Shi W, Yang Y, Nagasu H, Satoh M, Kidokoro K, Nishi Y, Ihoriya C, Kadoya H, Sasaki T, Kashihara N, Wu CF, Chang FC, Chen YT, Chou YH, Duffield J, Lin SL, Rocca C, Rocca C, Gregorini M, Corradetti V, Valsania T, Bedino G, Bosio F, Pattonieri EF, Esposito P, Sepe V, Libetta C, Rampino T, Dal Canton A, Bedino G, Gregorini M, Corradetti V, Rocca C, Pattonieri EF, Valsania T, Bosio F, Esposito P, Sepe V, Libetta C, Rampino T, Dal Canton A, Omori H, Kawada N, Inoue K, Ueda Y, Yamamoto R, Matsui I, Kaimori J, Takabatake Y, Moriyama T, Isaka Y, Rakugi H, Wasilewska A, Taranta-Janusz K, Deebek W, Kuroczycka-Saniutycz E, Lee AS, Lee AS, Lee JE, Jung YJ, Kang KP, Lee S, Kim W, Arfian N, Emoto N, Yagi K, Nakayama K, Hartopo AB, Nugrahaningsih DA, Yanagisawa M, Hirata KI, Munoz-Felix JM, Lopez-Novoa JM, Martinez-Salgado C, Oujo B, Munoz-Felix JM, Arevalo M, Bernabeu C, Perez-Barriocanal F, Lopez-Novoa JM, Jesper K, Nathalie V, Pierre G, Yi Chun DX, Alexandre H, Eric R, Iyoda M, Shibata T, Matsumoto K, Shindo-Hirai Y, Kuno Y, Wada Y, Akizawa T, Schwartz I, Schwartz D, Prot Bertoye C, Prot Bertoye C, Terryn S, Claver J, Beghdadi WB, Monteiro R, Blank U, Devuyst O, Daugas E, Van Beneden K, Geers C, Pauwels M, Mannaerts I, Van den Branden C, Van Grunsven LA, Seckin I, Pekpak M, Uzunalan M, Uruluer B, Kokturk S, Ozturk Z, Sonmez H, Yaprak E, Furuno Y, Tsutsui M, Morishita T, Shimokawa H, Otsuji Y, Yanagihara N, Kabashima N, Ryota S, Kanegae K, Miyamoto T, Nakamata J, Ishimatsu N, Tamura M, Nakagawa T, Nakagawa T, Ichikawa K, Miyamoto M, Takabayashi D, Yamazaki H, Kakeshita K, Koike T, Kagitani S, Tomoda F, Hamashima T, Ishii Y, Inoue H, Sasahara M, El Machhour F, Kerroch M, Mesnard L, Chatziantoniou C, Dussaule JC, Inui K, Sasai F, Maruta Y, Nishiwaki H, Kawashima E, Inoue Y, Yoshimura A, Matsumoto K, Matsumoto K, Iyoda M, Shibata T, Wada Y, Shindo-Hirai Y, Kuno Y, Akizawa T, Musacchio E, Priante G, Valvason C, Sartori L, Baggio B, Kim JH, Gross O, Diana R, Gry DH, Asimal B, Johanna T, Imke SE, Lydia W, Gerhard-Anton M, Hassan D, Cano JL, Griera M, Olmos G, Martin P, Cortes MA, Lopez-Ongil S, Rodriguez-Puyol D, DE Frutos S, Gonzalez M, DE Frutos S, Cano JL, Luengo A, Martin P, Rodriguez-Puyol M, Calleros L, Lupica R, Lacquaniti A, Donato V, Maggio R, Mastroeni C, Lucisano S, Cernaro V, Fazio MR, Quartarone A, Buemi M, Kacik M, Goedicke S, Eggert H, Hoyer JD, Wurm S, Wurm S, Steege A, Banas M, Kurtz A, Banas B, Lasagni L, Lazzeri E, Peired A, Angelotti ML, Ronconi E, Romoli S, Romagnani P, Schaefer I, Teng B, Worthmann K, Haller H, Schiffer M, Prattichizzo C, Netti GS, Rocchetti MT, Cormio L, Carrieri G, Stallone G, Grandaliano G, Ranieri E, Gesualdo L, Kucher A, Smirnov A, Parastayeva M, Beresneva O, Kayukov I, Zubina I, Ivanova G, Abed A, Schlekenbach L, Foglia B, Chatziantoniou C, Kwak B, Chadjichristos C, Queisser N, Schupp N, Brand S, Himer L, Himer L, Szebeni B, Sziksz E, Saijo S, Kis E, Prokai A, Banki NF, Fekete A, Tulassay T, Vannay A, Hegner B, Schaub T, Lange C, Dragun D, Klinkhammer BM, Rafael K, Monika M, Anna M, Van Roeyen C, Boor P, Eva Bettina B, Simon O, Esther S, Floege J, Kunter U, Hegner B, Janke D, Schaub T, Lange C, Jankowski J, Dragun D, Hayashi M, Takamatsu I, Horimai C, Yoshida T, Seno DI Marco G, Koenig M, Stock C, Reiermann S, Amler S, Koehler G, Fobker M, Buck F, Pavenstaedt H, Lang D, Brand M, Plotnikov E, Morosanova M, Pevzner I, Zorova L, Pulkova N, Zorov D, Wornle M, Ribeiro A, Belling F, Merkle M, Nakazawa D, Nishio S, Shibasaki S, Tomaru U, Akihiro I, Kobayashi I, Imanishi Y, Kurajoh M, Nagata Y, Yamagata M, Emoto M, Michigami T, Ishimura E, Inaba M, Nishi Y, Satoh M, Sasaki T, Kashihara N, Wu CC, Lu KC, Chen JS, Chu P, Lin YF, Eller K, Schroll A, Banas M, Kirsch A, Huber J, Weiss G, Theurl I, Rosenkranz AR, Zawada A, Rogacev K, Achenbach M, Fliser D, Held G, Heine GH, Miyamoto Y, Iwao Y, Watanabe H, Kadowaki D, Ishima Y, Chuang VTG, Sato K, Otagiri M, Maruyama T, Ueda Y, Iwatani H, Isaka Y, Watanabe H, Honda D, Miyamoto Y, Noguchi T, Kadowaki D, Ishima Y, Tanaka M, Tanaka H, Fukagawa M, Otagiri M, Maruyama T, Wornle M, Ribeiro A, Pircher J, Koppel S, Mannell H, Krotz F, Merkle M, Virzi GM, Bolin C, Cruz D, Scalzotto E, De Cal M, Vescovo G, Ronco C, Virzi GM, Bolin C, Cruz D, Scalzotto E, De Cal M, Vescovo G, Ronco C, Grobmayr R, Lech M, Ryu M, Anders HJ, Aoshima Y, Mizobuchi M, Ogata H, Kumata C, Nakazawa A, Kondo F, Ono N, Koiwa F, Kinugasa E, Akizawa T, Freisinger W, Lale N, Lampert A, Ditting T, Heinlein S, Schmieder RE, Veelken R, Nave H, Perthel R, Suntharalingam M, Bode-Boger S, Beutel G, Kielstein J, Rodrigues-Diez R, Rodrigues-Diez R, Rayego-Mateos S, Lavoz C, Stark Aroeira LG, Orejudo M, Alique M, Ortiz A, Egido J, Ruiz-Ortega M, Oskar W, Rusan C, Schaub T, Hegner B, Dragun D, Padberg JS, Wiesinger A, Brand M, Seno DI Marco G, Reuter S, Grabner A, Kentrup D, Lukasz A, Oberleithner H, Pavenstadt H, Kumpers P, Eberhardt HU, Skerka C, Chen Q, Hallstroem T, Hartmann A, Kemper MJ, Zipfel PF, N'gome-Sendeyo K, Fan QF, Zhang SY, Pawlak A, Sahali D, Wornle M, Ribeiro A, Merkle M, Toblli J, Toblli J, Cao G, Giani JF, Dominici FP, Kim JS, Yang JW, Kim MK, Han BG, Choi SO. Experimental pathology. Nephrol Dial Transplant 2012. [DOI: 10.1093/ndt/gfs241] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
148
|
Larkey LK, Herman PM, Roe DJ, Garcia F, Lopez A, Gonzalez J, Perera PN, Saboda K. A Cancer Screening Intervention for Underserved Latina Women by Lay Educators. J Womens Health (Larchmt) 2012; 21:557-66. [DOI: 10.1089/jwh.2011.3087] [Citation(s) in RCA: 58] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- Linda K. Larkey
- College of Nursing and Health Innovation, Arizona State University, Phoenix, Arizona
- Arizona Cancer Center, University of Arizona, Tucson, Arizona
| | | | - Denise J. Roe
- Arizona Cancer Center, University of Arizona, Tucson, Arizona
- Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, Arizona
| | | | - A.M. Lopez
- Arizona Cancer Center, University of Arizona, Tucson, Arizona
| | - J. Gonzalez
- College of Nursing and Health Innovation, Arizona State University, Phoenix, Arizona
| | | | | |
Collapse
|
149
|
Solano B, Ferrit M, Gonzalez J, Moya I, Sanchez E, Gonzalez C, Marquez E, Gomez A, Calleja M, Martinez F. Treatment schemes: from triple therapy to monotherapy in HIV patients: analysis of the efficacy and safety. Eur J Hosp Pharm 2012. [DOI: 10.1136/ejhpharm-2012-000074.199] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
|
150
|
Arrieta EE, Suárez-Berea M, Rodriguez-Jato T, Campano L, Rodriguez B, Touris M, Gonzalez J, Mosquera A, Suárez-Rodriguez A, Martínez-Bahamonde F. Evaluation of pharmacist clinical interventions profile in a university hospital. Eur J Hosp Pharm 2012. [DOI: 10.1136/ejhpharm-2012-000074.401] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|